MAPKAPK5
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00165 | S192 | Sugiyama | HAX1 HS1BP1 | VWPMDPHPRtREDNDLDsQVsQEGLGPVLQPQPKSYFKsIS |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00299 | S211 | Sugiyama | CLIC1 G6 NCC27 | CKKYRGFTIPEAFRGVHRYLsNAyAREEFAstCPDDEEIEL |
| O00299 | S221 | Sugiyama | CLIC1 G6 NCC27 | EAFRGVHRYLsNAyAREEFAstCPDDEEIELAyEQVAKALK |
| O00418 | S377 | GPS6|SIGNOR|iPTMNet|EPSD | EEF2K | CGsPQVRTLsGSRPPLLRPLsENSGDENMSDVTFDsLPSsP |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | S409 | Sugiyama | TRAFD1 FLN29 | CDQRPATATNHVTEGIPRLDsQPQEtsPELPRRRVRHQGDL |
| O14545 | T323 | Sugiyama | TRAFD1 FLN29 | ELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQ |
| O14672 | S630 | Sugiyama | ADAM10 KUZ MADM | TGSVQWSRHFSGRTITLQPGsPCNDFRGYCDVFMRCRLVDA |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14745 | S290 | Sugiyama | NHERF1 NHERF SLC9A3R1 | REALAEAALEsPRPALVRsAssDtsEELNsQDsPPKQDSTA |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15226 | T620 | Sugiyama | NKRF ITBA4 NRF | KIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQIA |
| O15460 | S531 | Sugiyama | P4HA2 UNQ290/PRO330 | KWVSNKWFHERGQEFLRPCGstEVD________________ |
| O43164 | S253 | Sugiyama | PJA2 KIAA0438 RNF131 | LDsVPLVKssAGDTEFVHQNsQEIQRSSQDEMVSTKQQNNT |
| O43390 | S426 | Sugiyama | HNRNPR HNRPR | IVLAKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPI |
| O43524 | S215 | GPS6|EPSD | FOXO3 FKHRL1 FOXO3A | KDKGDSNSSAGWKNsIRHNLsLHSRFMRVQNEGTGKssWWI |
| O43524 | S253 | GPS6|EPSD | FOXO3 FKHRL1 FOXO3A | WWIINPDGGKsGKAPRRRAVsMDNsNKYTKSRGRAAKKKAA |
| O43524 | S551 | GPS6|EPSD | FOXO3 FKHRL1 FOXO3A | QNLLHHQHQTQGALGGSRALsNsVsNMGLSESSSLGSAKHQ |
| O43524 | S555 | GPS6 | FOXO3 FKHRL1 FOXO3A | HHQHQTQGALGGSRALsNsVsNMGLSESSSLGSAKHQQQsP |
| O43615 | S180 | Sugiyama | TIMM44 MIMT44 TIM44 | AESVSKGGEKLGRTAAFRALsQGVEsVKKEIDDsVLGQtGP |
| O43707 | S763 | Sugiyama | ACTN4 | IARTINEVENQILtRDAKGIsQEQMQEFRASFNHFDKDHGG |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60229 | S487 | SIGNOR|EPSD|PSP | KALRN DUET DUO HAPIP TRAD | AYTEVSQDGKALLDVLQRPLsPGNSESLTATANYSKAVHQV |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75179 | S2045 | Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75369 | S1505 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PSQEGPYMVSVKYADEEIPRsPFKVKVLPTYDASKVtAsGP |
| O75376 | S158 | Sugiyama | NCOR1 KIAA1047 | RASADAKKDPAFGGKHEAPssPIsGQPCGDDQNAsPsKLSK |
| O75436 | T102 | Sugiyama | VPS26A VPS26 | KSNTHEFVNLVKELALPGELtQSRSYDFEFMQVEKPYESYI |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75569 | S18 | Sugiyama | PRKRA PACT RAX HSD-14 HSD14 | ___MSQSRHRAEAPPLEREDsGtFsLGKMITAKPGKTPIQV |
| O94888 | S280 | Sugiyama | UBXN7 KIAA0794 UBXD7 | EHGQLDGLsssPPKKCARsEsLIDAsEDsQLEAAIRASLQE |
| O94992 | S268 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EDGGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELI |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95155 | T27 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | DEIRRRRLARLAGGQtsQPttPLtsPQRENPPGPPIAASAP |
| O95155 | T30 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | RRRRLARLAGGQtsQPttPLtsPQRENPPGPPIAASAPGPs |
| O95239 | S1038 | Sugiyama | KIF4A KIF4 | FEYVPPKPKPSRVKEKFLEQsMDIEDLKYCSEHSVNEHEDG |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95453 | S557 | Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95625 | S511 | Sugiyama | ZBTB11 | TAKTDFGPDDDTYRSRLRQRsVNEGAYIRLHKGMEKKLQKR |
| O95816 | S73 | Sugiyama | BAG2 | KEILLEMIHSIQNSQDMRQIsDGEREELNLTANRLMGRTLT |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00966 | T219 | Sugiyama | ASS1 ASS | KNQAPPGLytKtQDPAKAPNtPDILEIEFKKGVPVKVTNVK |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04637 | S37 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53 P53 | EtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQWFtED |
| P04792 | S15 | Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S78 | GPS6|EPSD|Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | GPS6|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S177 | Sugiyama | KRT18 CYK18 PIG46 | ARLAADDFRVKyETELAMRQsVENDIHGLRKVIDDTNItRL |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P07101 | S19 | SIGNOR|PSP | TH TYH | __MPTPDATTPQAKGFRRAVsELDAKQAEAIMVRGQGAPGP |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07814 | S1511 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PGAKCVCGKNPAKyytLFGRsy___________________ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0C0L4 | S1294 | Sugiyama | C4A CO4 CPAMD2 | LHEGKAEMADQASAWLTRQGsFQGGFRSTQDTVIALDALSA |
| P0C0L5 | S1294 | Sugiyama | C4B CO4 CPAMD3; C4B_2 | LHEGKAEMADQAAAWLTRQGsFQGGFRSTQDTVIALDALSA |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | S362 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | RIPKIQKLLQDFFNGKELNKsINPDEAVAyGAAVQAAILsG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11586 | S872 | Sugiyama | MTHFD1 MTHFC MTHFD | YTKQGFGNLPICMAKtHLsLsHNPEQKGVPTGFILPIRDIR |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12956 | S477 | Sugiyama | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S447 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | PKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKVIRKKLVRK |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | S674 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | WsGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLI |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S536 | Sugiyama | EZR VIL2 | KRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNE |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15336 | T69 | Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15336 | T73 | Sugiyama | ATF2 CREB2 CREBP1 | LKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsPFE |
| P15374 | S128 | Sugiyama | UCHL3 | KDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRVtH |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P19338 | S591 | Sugiyama | NCL | SKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKG |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23381 | S467 | Sugiyama | WARS1 IFI53 WARS WRS | ARRKEVTDEIVKEFMTPRKLsFDFQ________________ |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P24666 | S119 | Sugiyama | ACP1 | DLNRKSNQVKTCKAKIELLGsYDPQKQLIIEDPyyGNDsDF |
| P24928 | S1913 | Sugiyama | POLR2A POLR2 | PtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPt |
| P24928 | S1920 | Sugiyama | POLR2A POLR2 | PVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKGstY |
| P24928 | Y1909 | Sugiyama | POLR2A POLR2 | sPtsPtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPt |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25685 | S149 | SIGNOR|EPSD|PSP | DNAJB1 DNAJ1 HDJ1 HSPF1 | DPFSGFPMGMGGFTNVNFGRsRsAQEPARKKQDPPVTHDLR |
| P25685 | S151 | SIGNOR|EPSD|PSP | DNAJB1 DNAJ1 HDJ1 HSPF1 | FSGFPMGMGGFTNVNFGRsRsAQEPARKKQDPPVTHDLRVs |
| P25685 | S171 | SIGNOR|EPSD|PSP | DNAJB1 DNAJ1 HDJ1 HSPF1 | sAQEPARKKQDPPVTHDLRVsLEEIysGCtKKMKISHKRLN |
| P25705 | S65 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | KtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARVH |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | T465 | Sugiyama | MSN | WQQKAQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDE |
| P26232 | T653 | Sugiyama | CTNNA2 CAPR | PEELEDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26639 | S702 | Sugiyama | TARS1 TARS | ISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEE |
| P27695 | S143 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | sDKEGysGVGLLsRQCPLKVsyGIGDEEHDQEGRVIVAEFD |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | S247 | Sugiyama | LRPAP1 A2MRAP | KLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSA |
| P31152 | S186 | SIGNOR | MAPK4 ERK4 PRKM4 | IGDFGLARIVDQHYSHKGYLsEGLVTKWYRsPRLLLSPNNY |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31946 | S132 | Sugiyama | YWHAB | TQPESKVFyLKMKGDYFRyLsEVAsGDNKQTtVsNsQQAyQ |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32969 | S137 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | FLGEKYIRRVRMRPGVACsVsQAQKDELILEGNDIELVSNS |
| P33176 | S57 | Sugiyama | KIF5B KNS KNS1 | DTVVIASKPYAFDRVFQSsTsQEQVyNDCAKKIVKDVLEGy |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P34897 | T420 | Sugiyama | SHMT2 | LELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFREDD |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35221 | T654 | Sugiyama | CTNNA1 | tPEELDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35637 | S346 | Sugiyama | FUS TLS | TDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFsGNPIKV |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36915 | S68 | Sugiyama | GNL1 HSR1 | tDtsDGEsVTHHIRRLNQQPsQGLGPRGYDPNRYRLHFERD |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40222 | S514 | Sugiyama | TXLNA TXLN | GsLtDsGPERRPEGPGAQAPssPRVtEAPCyPGAPSTEASG |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41212 | S439 | Sugiyama | ETV6 TEL TEL1 | FMKTPDEIMSGRTDRLEHLEsQELDEQIyQEDEC_______ |
| P42704 | S1027 | Sugiyama | LRPPRC LRP130 | VPFDVPELWyEDEKHsLNsssAsttEPDFQKDILIACRLNQ |
| P42704 | S742 | Sugiyama | LRPPRC LRP130 | CRHDKVEDALNLKEEFDRLDssAVLDTGKYVGLVRVLAKHG |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S308 | Sugiyama | MKI67 | VSRKSRPKsGGsGHAVAEPAsPEQELDQNKGKGRDVEsVQt |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P47712 | S727 | SIGNOR|iPTMNet|EPSD|Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49368 | S244 | Sugiyama | CCT3 CCTG TRIC5 | VTHPRMRRYIKNPRIVLLDssLEyKKGEsQtDIEITREEDF |
| P49368 | S252 | Sugiyama | CCT3 CCTG TRIC5 | YIKNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEE |
| P49588 | S249 | Sugiyama | AARS1 AARS | ILKPLPKKsIDtGMGLERLVsVLQNKMSNYDTDLFVPYFEA |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S265 | Sugiyama | HNRNPF HNRPF | EySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQs |
| P52597 | S269 | Sugiyama | HNRNPF HNRPF | LSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsTTGH |
| P52907 | S123 | Sugiyama | CAPZA1 | KEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNGFCTV |
| P52907 | S219 | Sugiyama | CAPZA1 | YEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENAENEy |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S457 | Sugiyama | ACLY | FLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQD |
| P53992 | S378 | Sugiyama | SEC24C KIAA0079 | TTNFLVKDQGNASPRYIRCTsyNIPCTSDMAKQAQVPLAAV |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55072 | S459 | Sugiyama | VCP HEL-220 HEL-S-70 | AEVMNSLAVTMDDFRWALSQsNPSALRETVVEVPQVTWEDI |
| P55072 | S765 | Sugiyama | VCP HEL-220 HEL-S-70 | RsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGAGPsQ |
| P55081 | S132 | Sugiyama | MFAP1 | VVGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMM |
| P55081 | S133 | Sugiyama | MFAP1 | VGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMMR |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60842 | S394 | Sugiyama | EIF4A1 DDX2A EIF4A | NMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI________ |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P60900 | T173 | Sugiyama | PSMA6 PROS27 | KCDPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQ |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61758 | T45 | Sugiyama | VBP1 PFDN3 | IPEAVFVEDVDSFMKQPGNEtADtVLKKLDEQYQKYKFMEL |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63010 | S531 | Sugiyama | AP2B1 ADTB2 CLAPB1 | TQDSDNPDLRDRGyIyWRLLsTDPVTAKEVVLSEKPLISEE |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78371 | S143 | Sugiyama | CCT2 99D8.1 CCTB | PQTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIA |
| P78371 | S150 | Sugiyama | CCT2 99D8.1 CCTB | WREATKAAREALLssAVDHGsDEVKFRQDLMNIAGTTLssK |
| P78527 | S3366 | Sugiyama | PRKDC HYRC HYRC1 | ACLAEIEEDKARRILELsGsssEDsEKVIAGLyQRAFQHLS |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q00341 | S904 | Sugiyama | HDLBP HBP VGL | FHRSVMGPKGSRIQQITRDFsVQIKFPDREENAVHSTEPVV |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01650 | S35 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | AAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNITLLNG |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q06124 | S140 | Sugiyama | PTPN11 PTP2C SHPTP2 | KEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTGDDKGES |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1111 | Sugiyama | TJP1 ZO1 | WsyYDDKQPYPsRPPFDNQHsQDLDSRQHPEESSERGyFPR |
| Q07666 | S35 | Sugiyama | KHDRBS1 SAM68 | sGRsGsMDPsGAHPsVRQtPsRQPPLPHRSRGGGGGSRGGA |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09666 | T3716 | Sugiyama | AHNAK PM227 | VEGDLKGPEVDIKGPKVDIDtPDINIEGsEGKFKGPKFKIP |
| Q09666 | T4100 | Sugiyama | AHNAK PM227 | VDVNLPKADIDVsGPKVDIDtPDIDIHGPEGKLKGPKFKMP |
| Q10567 | S531 | Sugiyama | AP1B1 ADTB1 BAM22 CLAPB2 | TQDSDNPDLRDRGyIyWRLLsTDPVAAKEVVLAEKPLISEE |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q12965 | S1002 | Sugiyama | MYO1E MYO1C | RSNQKSLyTsMARPPLPRQQstssDRVsQtPEsLDFLKVPD |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14204 | S2384 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FSEDVLSTDMIFNNFLARLRsIPLDEGEDEAQRRRKGKEDE |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15021 | S1330 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | sQRAPsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHP |
| Q15293 | S315 | Sugiyama | RCN1 RCN | NKDEKLTKEEILENWNMFVGsQAtNyGEDLtKNHDEL____ |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15382 | S130 | SIGNOR|EPSD|PSP | RHEB RHEB2 | VQIPIMLVGNKKDLHMERVIsYEEGKALAEsWNAAFLEssA |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15759 | S32 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | ELNKTVWEVPQRLQGLRPVGsGAyGsVCsAyDARLRQKVAV |
| Q15759 | S40 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | VPQRLQGLRPVGsGAyGsVCsAyDARLRQKVAVKKLSRPFQ |
| Q15759 | T180 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | EDCELRILDFGLARQADEEMtGyVAtRWYRAPEIMLNWMHY |
| Q15759 | Y182 | Sugiyama | MAPK11 PRKM11 SAPK2 SAPK2B | CELRILDFGLARQADEEMtGyVAtRWYRAPEIMLNWMHYNQ |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q2KHR3 | S1231 | Sugiyama | QSER1 | sPsDKVDNELKNLEHLssFssDEDDPGYSQDAYKSVstPLT |
| Q2VIQ3 | S1038 | Sugiyama | KIF4B | FEYIPPKPKPSRVKEKFLEQsMDIEDLKYCSEHSVNEHEDG |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q53EL6 | T93 | Sugiyama | PDCD4 H731 | RGDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLP |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71RC2 | S74 | Sugiyama | LARP4 PP13296 | PEGNAELSEDICKEYEVMySssCETTRNTTGIEESTDGMIL |
| Q71RC2 | S75 | Sugiyama | LARP4 PP13296 | EGNAELSEDICKEYEVMySssCETTRNTTGIEESTDGMILG |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7LBC6 | S810 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | PFEAVKRFsLDERSLACRQDsDSSTNsDLSDLSDSEEQLQA |
| Q7Z2W4 | S364 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | PGstyLASNsTsAPNWKsLtsWtNDQGARRKtVFsPtLPAA |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z5K2 | S223 | Sugiyama | WAPL FOE KIAA0261 WAPAL | EIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDF |
| Q86U86 | S948 | Sugiyama | PBRM1 BAF180 PB1 | AEKsEDssGAAGLSGLHRtYsQDCsFKNSMYHVGDYVYVEP |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86W56 | S286 | Sugiyama | PARG | VGSEDVGTGPKNDNKLTRQEsCLGNsPPFEKESEPEsPMDV |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IW41 | S206 | Sugiyama | MAPKAPK5 PRAK | tPyYVAPQVLEAQRRHQKEKsGIIPtsPtPYTYNKSCDLWS |
| Q8IW41 | S212 | Sugiyama | MAPKAPK5 PRAK | PQVLEAQRRHQKEKsGIIPtsPtPYTYNKSCDLWSLGVIIY |
| Q8IW41 | S33 | Sugiyama | MAPKAPK5 PRAK | ETSILEEYSINWTQKLGAGIsGPVRVCVKKSTQERFALKIL |
| Q8IW41 | S386 | Sugiyama | MAPKAPK5 PRAK | LGTKPKDSVYIHDHENGAEDsNVALEKLRDVIAQCILPQAG |
| Q8IW41 | S438 | Sugiyama | MAPKAPK5 PRAK | VMQEAWKYNRECKLLRDTLQsFsWNGRGFTDKVDRLKLAEI |
| Q8IW41 | S440 | Sugiyama | MAPKAPK5 PRAK | QEAWKYNRECKLLRDTLQsFsWNGRGFTDKVDRLKLAEIVK |
| Q8IW41 | T182 | Sugiyama | MAPKAPK5 PRAK | DAPVKLCDFGFAKIDQGDLMtPQFtPyYVAPQVLEAQRRHQ |
| Q8IW41 | T186 | Sugiyama | MAPKAPK5 PRAK | KLCDFGFAKIDQGDLMtPQFtPyYVAPQVLEAQRRHQKEKs |
| Q8IW41 | T211 | Sugiyama | MAPKAPK5 PRAK | APQVLEAQRRHQKEKsGIIPtsPtPYTYNKSCDLWSLGVII |
| Q8IW41 | Y188 | Sugiyama | MAPKAPK5 PRAK | CDFGFAKIDQGDLMtPQFtPyYVAPQVLEAQRRHQKEKsGI |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N556 | S264 | Sugiyama | AFAP1 AFAP | IKEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssD |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8ND56 | S300 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GRFGIRRDGPMKFEKDFDFEsANAQFNKEEIDREFHNKLKL |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8NI08 | S208 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | DKLPDADLARKALKPIERVLsstsEEDEPGVVKFLKMNCRY |
| Q8WUI4 | S109 | Sugiyama | HDAC7 HDAC7A | LAEVILKKQQAALERtVHPNsPGIPYRTLEPLETEGATRSM |
| Q8WUM0 | S309 | Sugiyama | NUP133 | LTSSNISKWELDDSSEKHAYsWDINRALKENITDAIWGSES |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q8WYL5 | S441 | Sugiyama | SSH1 KIAA1298 SSH1L | NYVKQKRSITRPNAGFMRQLsEYEGILDASKQRHNKLWRQQ |
| Q92499 | S113 | Sugiyama | DDX1 | MNPYDRGSAFAIGSDGLCCQsREVKEWHGCRATKGLMKGKH |
| Q92599 | S163 | EPSD|PSP | SEPTIN8 KIAA0202 SEPT8 | FDYHDTRIHVCLYFITPTGHsLKSLDLVTMKKLDSKVNIIP |
| Q92599 | S192 | EPSD|PSP | SEPTIN8 KIAA0202 SEPT8 | MKKLDSKVNIIPIIAKADTIsKSELHKFKIKIMGELVSNGV |
| Q92614 | S728 | Sugiyama | MYO18A CD245 KIAA0216 MYSPDZ TIAF1 | ELSSAIFKHQHKGGTLQRstsFRQGPEEsGLGDGTGPKLSA |
| Q92804 | S295 | Sugiyama | TAF15 RBP56 TAF2N | TDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFHGNIIKV |
| Q92945 | S181 | Sugiyama | KHSRP FUBP2 | GRGGEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsV |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96C86 | T25 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | APQLGKRKRELDVEEAHAAstEEKEAGVGNGTCAPVRLPFS |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96E11 | S239 | Sugiyama | MRRF | LKKSKDTVsEDtIRLIEKQIsQMADDtVAELDRHLAVKTKE |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q96MH2 | S194 | Sugiyama | HEXIM2 L3 | EAGDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELV |
| Q96MH2 | T196 | Sugiyama | HEXIM2 L3 | GDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELVRD |
| Q96S55 | T116 | Sugiyama | WRNIP1 WHIP | GEEGDDGGETESREsyDAPPtPsGARLIPDFPVARsssPGR |
| Q99426 | S110 | Sugiyama | TBCB CG22 CKAP1 | HsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRsKL |
| Q99426 | S76 | Sugiyama | TBCB CG22 CKAP1 | LYGVDDKFYsKLDQEDALLGsYPVDDGCRIHVIDHsGARLG |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BVC4 | S43 | Sugiyama | MLST8 GBL LST8 | TVRFWQAHSGICTRTVQHQDsQVNALEVTPDRSMIAAAGYQ |
| Q9BW71 | S357 | Sugiyama | HIRIP3 | EDsGKGEPTAKGSRKMARLGstsGEEsDLEREVsDsEAGGG |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZD4 | S171 | Sugiyama | NUF2 CDCA1 NUF2R | KMQQLNAAHQEALMKLERLDsVPVEEQEEFKQLSDGIQELQ |
| Q9C0C9 | S399 | Sugiyama | UBE2O KIAA1734 | EGsMAKKVKRLLKKQVVRIMsCsPDtQCsRDHsMEDPDKKG |
| Q9GZZ9 | S44 | Sugiyama | UBA5 UBE1DC1 | sLQVPRSGDGGGGRVRIEKMssEVVDSNPysRLMALKRMGI |
| Q9H0K1 | T589 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | KREVHNRsPVsFREGRRAsDtsLtQGIVAFRQHLQNLARTK |
| Q9H0K1 | T592 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | VHNRsPVsFREGRRAsDtsLtQGIVAFRQHLQNLARTKGIL |
| Q9H2K8 | S324 | Sugiyama | TAOK3 DPK JIK KDS MAP3K18 | QyRKMKKILFQETRNGPLNEsQEDEEDsEHGTsLNREMDSL |
| Q9H2U2 | S315 | Sugiyama | PPA2 HSPC124 | ISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK_ |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H4A3 | S2029 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GPssDPEAAFLSRDVDDGsGsPHsPHQLssKSLPSQNLSQS |
| Q9H4A3 | S2032 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | sDPEAAFLSRDVDDGsGsPHsPHQLssKSLPSQNLSQSLSN |
| Q9H4L5 | S30 | Sugiyama | OSBPL3 KIAA0704 ORP3 OSBP3 | VSQKLVsPsRsTSSCSSKQGsRQDsWEVVEGLRGEMNYTQE |
| Q9H4L5 | S34 | Sugiyama | OSBPL3 KIAA0704 ORP3 OSBP3 | LVsPsRsTSSCSSKQGsRQDsWEVVEGLRGEMNYTQEPPVQ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H814 | S298 | Sugiyama | PHAX RNUXA | NGSRRRTPGGVFLNLLKNtPsISEEQIKDIFyIENQKEYEN |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NW68 | S17 | Sugiyama | BSDC1 UNQ2494/PRO5781 | ____MAEGEDVGWWRSWLQQsYQAVKEKSSEALEFMKRDLT |
| Q9NYF8 | S198 | Sugiyama | BCLAF1 BTF KIAA0164 | PLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGLsA |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UHD2 | S510 | Sugiyama | TBK1 NAK | LEAAELGEISDIHTKLLRLsssQGTIETSLQDIDSRLsPGG |
| Q9UHI6 | S647 | Sugiyama | DDX20 DP103 GEMIN3 | QNGFVRNKVIEQRVPVLASSsQsGDsEsDSDSySSRTSSQS |
| Q9UHX1 | S461 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | sIsGssARHMVMQKLLRKQEsTVMVLRNMVDPKDIDDDLEG |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UKS6 | S341 | Sugiyama | PACSIN3 | DEVtLtsIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRK |
| Q9UKV3 | S987 | Sugiyama | ACIN1 ACINUS KIAA0670 | EVKKVTLGDtLtRRsIsQQKsGVsITIDDPVRtAQVPsPPR |
| Q9UKV3 | S990 | Sugiyama | ACIN1 ACINUS KIAA0670 | KVTLGDtLtRRsIsQQKsGVsITIDDPVRtAQVPsPPRGKI |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9ULD2 | T1204 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRLs |
| Q9UNF1 | S265 | Sugiyama | MAGED2 BCG1 | LRsPKARRGKARRRAAKLQssQEPEAPPPRDVALLQGRAND |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPN3 | S2769 | Sugiyama | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | EAIEKRLISPELANMIQIDSsEFSDHRAQIEKQEGIEVCAL |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S178 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NVKDKLCSKRtDLCDHALHIsHDEL________________ |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2U5 | S239 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | SLDSPLDGESYPKSRMPRAQsyPDNHQEFSDyDNPIFEKFG |
| Q9Y3X0 | S386 | Sugiyama | CCDC9 | DRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEIPAPAH |
| Q9Y3X0 | T381 | Sugiyama | CCDC9 | YsDHDDRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEI |
| Q9Y4X5 | S514 | Sugiyama | ARIH1 ARI MOP6 UBCH7BP HUSSY-27 | NQADLENATEVLSGYLERDIsQDsLQDIKQKVQDKYRYCES |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 2.902434e-07 | 6.537 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.090464e-07 | 6.293 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.120924e-06 | 5.673 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.069165e-05 | 4.971 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.180282e-05 | 4.928 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.767308e-05 | 4.753 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.930482e-05 | 4.533 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.930482e-05 | 4.533 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.250303e-05 | 4.648 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.377862e-05 | 4.624 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.424535e-05 | 4.354 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.355520e-05 | 4.271 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.230441e-05 | 4.141 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.840394e-05 | 4.106 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.245223e-05 | 4.034 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.461330e-04 | 3.835 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.755367e-04 | 3.756 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.740453e-04 | 3.759 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.439055e-04 | 3.613 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.979196e-04 | 3.526 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.104296e-04 | 3.508 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.725865e-04 | 3.429 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.724709e-04 | 3.429 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.887830e-04 | 3.410 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.264820e-04 | 3.370 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.520111e-04 | 3.345 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.056095e-04 | 3.296 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.622866e-04 | 3.250 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.144774e-04 | 3.089 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.598134e-04 | 3.066 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.892952e-04 | 3.005 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.944540e-04 | 3.002 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.059998e-03 | 2.975 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.361643e-03 | 2.866 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.482753e-03 | 2.829 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.655204e-03 | 2.781 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.759252e-03 | 2.755 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.945543e-03 | 2.711 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.945543e-03 | 2.711 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.945543e-03 | 2.711 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.820757e-03 | 2.740 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.945543e-03 | 2.711 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.117700e-03 | 2.674 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.161844e-03 | 2.665 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.236081e-03 | 2.651 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.236081e-03 | 2.651 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.427356e-03 | 2.615 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.445366e-03 | 2.612 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.595302e-03 | 2.586 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.642654e-03 | 2.578 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.661184e-03 | 2.575 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.791891e-03 | 2.554 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.899418e-03 | 2.538 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.954055e-03 | 2.530 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.434278e-03 | 2.464 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.311288e-03 | 2.480 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.393680e-03 | 2.469 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.059992e-03 | 2.514 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.701747e-03 | 2.432 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.710666e-03 | 2.431 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.874371e-03 | 2.312 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.699039e-03 | 2.328 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.927877e-03 | 2.307 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.084894e-03 | 2.294 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.444681e-03 | 2.352 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.867865e-03 | 2.313 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.348910e-03 | 2.362 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.538637e-03 | 2.343 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.040880e-03 | 2.297 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.415508e-03 | 2.266 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.454146e-03 | 2.263 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.774538e-03 | 2.238 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.129663e-03 | 2.213 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.947376e-03 | 2.226 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.237033e-03 | 2.205 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.171837e-03 | 2.210 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 6.390962e-03 | 2.194 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 6.390962e-03 | 2.194 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.542831e-03 | 2.184 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.993534e-03 | 2.155 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.993534e-03 | 2.155 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.993534e-03 | 2.155 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.820133e-03 | 2.166 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.820133e-03 | 2.166 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.993534e-03 | 2.155 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.620577e-03 | 2.179 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.576196e-03 | 2.121 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.391561e-03 | 2.131 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.356963e-03 | 2.133 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.236653e-03 | 2.140 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.265401e-03 | 2.139 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.633271e-03 | 2.117 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.663721e-03 | 2.116 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.798449e-03 | 2.108 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.935646e-03 | 2.100 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.045609e-03 | 2.044 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.387534e-03 | 2.027 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.920217e-03 | 2.050 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.855061e-03 | 2.053 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.851729e-03 | 2.006 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.949609e-03 | 2.002 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.047634e-02 | 1.980 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.047634e-02 | 1.980 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.058717e-02 | 1.975 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.078383e-02 | 1.967 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.124586e-02 | 1.949 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.170937e-02 | 1.931 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.179447e-02 | 1.928 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.179447e-02 | 1.928 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.179447e-02 | 1.928 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.142481e-02 | 1.942 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.199813e-02 | 1.921 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.199983e-02 | 1.921 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.243428e-02 | 1.905 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.327080e-02 | 1.877 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.251928e-02 | 1.902 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.258971e-02 | 1.900 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.259555e-02 | 1.900 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.329146e-02 | 1.876 | 1 | 1 |
| Cellular Senescence | R-HSA-2559583 | 1.229453e-02 | 1.910 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.265380e-02 | 1.898 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.342807e-02 | 1.872 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.397687e-02 | 1.855 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.397687e-02 | 1.855 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.450296e-02 | 1.839 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.468931e-02 | 1.833 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.479778e-02 | 1.830 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.494071e-02 | 1.826 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.537060e-02 | 1.813 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.676298e-02 | 1.776 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.714998e-02 | 1.766 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.620784e-02 | 1.790 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.810323e-02 | 1.742 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.821960e-02 | 1.739 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.845834e-02 | 1.734 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.851759e-02 | 1.732 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.872401e-02 | 1.728 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.031264e-02 | 1.692 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.033412e-02 | 1.692 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.033412e-02 | 1.692 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.040931e-02 | 1.690 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.040931e-02 | 1.690 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.169043e-02 | 1.664 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.298053e-02 | 1.639 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.150272e-02 | 1.668 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.304357e-02 | 1.637 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.318610e-02 | 1.635 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.326710e-02 | 1.633 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.399107e-02 | 1.620 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.409284e-02 | 1.618 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.470492e-02 | 1.607 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.546975e-02 | 1.594 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.556782e-02 | 1.592 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.624071e-02 | 1.581 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.630542e-02 | 1.580 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.643970e-02 | 1.578 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.647139e-02 | 1.577 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.860214e-02 | 1.544 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.917891e-02 | 1.535 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.949497e-02 | 1.530 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.903873e-02 | 1.537 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.822036e-02 | 1.549 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.822036e-02 | 1.549 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.752032e-02 | 1.560 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.953320e-02 | 1.530 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.110239e-02 | 1.507 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.213965e-02 | 1.493 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.222962e-02 | 1.492 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.366096e-02 | 1.473 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.383375e-02 | 1.471 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.385241e-02 | 1.470 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.402493e-02 | 1.468 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.472924e-02 | 1.459 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.482468e-02 | 1.458 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.550515e-02 | 1.450 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.562870e-02 | 1.448 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.599808e-02 | 1.444 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.661456e-02 | 1.436 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.685541e-02 | 1.433 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.685541e-02 | 1.433 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.685541e-02 | 1.433 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.768280e-02 | 1.424 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.827722e-02 | 1.417 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.290846e-02 | 1.367 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.055030e-02 | 1.392 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.355290e-02 | 1.361 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.545394e-02 | 1.342 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.545394e-02 | 1.342 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.545394e-02 | 1.342 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.545394e-02 | 1.342 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.554611e-02 | 1.342 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.600811e-02 | 1.337 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.742330e-02 | 1.324 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.807155e-02 | 1.318 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.808688e-02 | 1.318 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.811071e-02 | 1.318 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.830321e-02 | 1.316 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.927726e-02 | 1.307 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.948864e-02 | 1.305 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 5.140937e-02 | 1.289 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.140937e-02 | 1.289 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.368075e-02 | 1.270 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.679702e-02 | 1.246 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.679702e-02 | 1.246 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.659973e-02 | 1.247 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.540920e-02 | 1.256 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.662319e-02 | 1.247 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.433167e-02 | 1.265 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.970185e-02 | 1.304 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.202178e-02 | 1.284 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.970185e-02 | 1.304 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.368075e-02 | 1.270 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.679702e-02 | 1.246 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.249930e-02 | 1.280 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.495539e-02 | 1.260 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.730906e-02 | 1.242 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.876716e-02 | 1.231 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.997468e-02 | 1.222 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.202088e-02 | 1.207 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.202088e-02 | 1.207 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.202088e-02 | 1.207 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.222368e-02 | 1.206 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.222368e-02 | 1.206 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.222368e-02 | 1.206 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.222368e-02 | 1.206 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.222368e-02 | 1.206 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.222368e-02 | 1.206 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 7.354241e-02 | 1.133 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.354241e-02 | 1.133 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.354241e-02 | 1.133 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.354241e-02 | 1.133 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.294109e-02 | 1.137 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.457792e-02 | 1.190 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.361184e-02 | 1.196 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.361184e-02 | 1.196 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.992422e-02 | 1.155 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.649291e-02 | 1.177 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.390885e-02 | 1.131 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.144687e-02 | 1.146 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.879458e-02 | 1.162 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.879458e-02 | 1.162 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.912189e-02 | 1.160 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.879458e-02 | 1.162 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 7.354241e-02 | 1.133 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.652055e-02 | 1.177 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.457792e-02 | 1.190 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.371775e-02 | 1.196 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.354241e-02 | 1.133 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.364802e-02 | 1.196 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.395911e-02 | 1.131 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.395911e-02 | 1.131 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.903344e-02 | 1.102 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.912035e-02 | 1.102 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.985060e-02 | 1.098 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.985060e-02 | 1.098 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.459784e-02 | 1.073 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 8.459784e-02 | 1.073 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.459784e-02 | 1.073 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 8.459784e-02 | 1.073 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.459784e-02 | 1.073 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.459784e-02 | 1.073 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.459784e-02 | 1.073 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.459784e-02 | 1.073 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.616343e-02 | 1.017 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.616343e-02 | 1.017 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.464640e-02 | 1.072 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.464640e-02 | 1.072 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.464640e-02 | 1.072 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.464640e-02 | 1.072 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.252773e-02 | 1.083 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.880831e-02 | 1.052 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.759779e-02 | 1.058 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.208124e-02 | 1.086 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.597129e-02 | 1.066 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.519549e-02 | 1.021 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.616343e-02 | 1.017 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.372887e-02 | 1.077 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.434956e-02 | 1.074 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.323269e-02 | 1.030 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.098924e-02 | 1.092 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.616343e-02 | 1.017 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.208124e-02 | 1.086 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.098924e-02 | 1.092 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.278613e-02 | 1.082 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.880831e-02 | 1.052 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.412050e-02 | 1.026 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.412050e-02 | 1.026 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.850797e-02 | 1.053 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.248543e-02 | 1.084 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.616343e-02 | 1.017 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.567002e-02 | 1.019 | 1 | 1 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.453665e-02 | 1.024 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 9.662436e-02 | 1.015 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.723493e-02 | 1.012 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.824009e-02 | 1.008 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.833604e-02 | 1.007 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.024997e-01 | 0.989 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.031351e-01 | 0.987 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.054261e-01 | 0.977 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.075178e-01 | 0.969 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.075178e-01 | 0.969 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.075178e-01 | 0.969 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.094071e-01 | 0.961 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.094642e-01 | 0.961 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.096082e-01 | 0.960 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.096082e-01 | 0.960 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.106643e-01 | 0.956 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.133935e-01 | 0.945 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.139347e-01 | 0.670 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.139347e-01 | 0.670 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.139347e-01 | 0.670 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.139347e-01 | 0.670 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.224580e-01 | 0.912 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.224580e-01 | 0.912 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.635047e-01 | 0.786 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.635047e-01 | 0.786 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.635047e-01 | 0.786 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.635047e-01 | 0.786 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.635047e-01 | 0.786 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.635047e-01 | 0.786 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.635047e-01 | 0.786 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.635047e-01 | 0.786 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.635047e-01 | 0.786 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.635047e-01 | 0.786 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 3.030798e-01 | 0.518 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.030798e-01 | 0.518 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.030798e-01 | 0.518 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.030798e-01 | 0.518 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.030798e-01 | 0.518 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.030798e-01 | 0.518 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.030798e-01 | 0.518 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.030798e-01 | 0.518 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.030798e-01 | 0.518 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.030798e-01 | 0.518 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.030798e-01 | 0.518 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.030798e-01 | 0.518 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.212195e-01 | 0.916 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.212195e-01 | 0.916 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.212195e-01 | 0.916 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.212195e-01 | 0.916 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.212195e-01 | 0.916 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.065295e-01 | 0.685 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.065295e-01 | 0.685 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 2.065295e-01 | 0.685 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.065295e-01 | 0.685 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.065295e-01 | 0.685 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.065295e-01 | 0.685 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.065295e-01 | 0.685 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.065295e-01 | 0.685 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.065295e-01 | 0.685 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.483615e-01 | 0.829 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.483615e-01 | 0.829 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.483615e-01 | 0.829 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.483615e-01 | 0.829 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.296151e-01 | 0.887 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.772319e-01 | 0.751 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.772319e-01 | 0.751 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.772319e-01 | 0.751 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.772319e-01 | 0.751 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.772319e-01 | 0.751 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.505565e-01 | 0.601 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.505565e-01 | 0.601 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.505565e-01 | 0.601 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.505565e-01 | 0.601 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.505565e-01 | 0.601 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.505565e-01 | 0.601 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.505565e-01 | 0.601 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.505565e-01 | 0.601 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.821199e-01 | 0.418 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.821199e-01 | 0.418 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.821199e-01 | 0.418 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.821199e-01 | 0.418 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.821199e-01 | 0.418 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.821199e-01 | 0.418 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.821199e-01 | 0.418 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.074780e-01 | 0.683 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.292749e-01 | 0.888 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.739724e-01 | 0.760 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.739724e-01 | 0.760 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.948058e-01 | 0.530 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.948058e-01 | 0.530 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 2.948058e-01 | 0.530 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.948058e-01 | 0.530 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.254929e-01 | 0.901 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.387609e-01 | 0.622 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.387609e-01 | 0.622 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.387609e-01 | 0.622 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.387609e-01 | 0.622 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.978600e-01 | 0.704 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.978600e-01 | 0.704 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.978600e-01 | 0.704 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.662131e-01 | 0.779 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.202490e-01 | 0.920 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.202490e-01 | 0.920 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.144188e-01 | 0.942 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.337175e-01 | 0.874 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.226653e-01 | 0.652 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.226653e-01 | 0.652 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.707618e-01 | 0.567 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.707618e-01 | 0.567 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.386611e-01 | 0.470 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.386611e-01 | 0.470 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.386611e-01 | 0.470 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.386611e-01 | 0.470 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.521998e-01 | 0.345 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 4.521998e-01 | 0.345 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.521998e-01 | 0.345 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.521998e-01 | 0.345 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.521998e-01 | 0.345 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.521998e-01 | 0.345 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.521998e-01 | 0.345 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.521998e-01 | 0.345 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.521998e-01 | 0.345 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.521998e-01 | 0.345 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.521998e-01 | 0.345 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.521998e-01 | 0.345 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.521998e-01 | 0.345 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.741673e-01 | 0.759 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.482207e-01 | 0.605 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.120868e-01 | 0.950 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.120868e-01 | 0.950 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.302775e-01 | 0.885 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.302775e-01 | 0.885 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.031862e-01 | 0.518 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.031862e-01 | 0.518 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.031862e-01 | 0.518 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.031862e-01 | 0.518 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.031862e-01 | 0.518 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.031862e-01 | 0.518 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.031862e-01 | 0.518 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.031862e-01 | 0.518 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.031862e-01 | 0.518 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.031862e-01 | 0.518 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.031862e-01 | 0.518 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.031862e-01 | 0.518 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.657187e-01 | 0.781 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.102765e-01 | 0.677 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.743613e-01 | 0.562 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.816430e-01 | 0.418 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.816430e-01 | 0.418 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.816430e-01 | 0.418 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.240999e-01 | 0.906 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.943169e-01 | 0.711 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.292408e-01 | 0.640 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.292408e-01 | 0.640 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.357664e-01 | 0.474 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.109503e-01 | 0.676 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.947332e-01 | 0.711 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.009272e-01 | 0.522 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.726112e-01 | 0.564 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.487210e-01 | 0.604 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.346392e-01 | 0.871 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.099767e-01 | 0.678 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.079981e-01 | 0.682 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.686471e-01 | 0.571 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.686471e-01 | 0.571 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.955023e-01 | 0.529 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.955023e-01 | 0.529 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.277653e-01 | 0.484 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.682628e-01 | 0.434 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.682628e-01 | 0.434 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.233857e-01 | 0.373 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.233857e-01 | 0.373 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.143349e-01 | 0.289 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 5.143349e-01 | 0.289 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.143349e-01 | 0.289 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.143349e-01 | 0.289 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.143349e-01 | 0.289 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.143349e-01 | 0.289 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.417598e-01 | 0.617 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.417598e-01 | 0.617 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.417598e-01 | 0.617 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.582236e-01 | 0.588 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.327362e-01 | 0.633 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.095543e-01 | 0.509 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.004641e-01 | 0.397 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.004641e-01 | 0.397 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.004641e-01 | 0.397 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.750162e-01 | 0.561 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.636176e-01 | 0.334 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.636176e-01 | 0.334 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.636176e-01 | 0.334 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.636176e-01 | 0.334 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.760756e-01 | 0.559 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.094254e-01 | 0.509 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.999500e-01 | 0.523 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.321863e-01 | 0.364 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.045819e-01 | 0.689 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.891316e-01 | 0.410 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.725086e-01 | 0.429 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.926628e-01 | 0.534 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.771587e-01 | 0.423 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.126004e-01 | 0.384 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.351013e-01 | 0.361 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 4.632722e-01 | 0.334 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 4.632722e-01 | 0.334 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.021446e-01 | 0.299 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.021446e-01 | 0.299 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 5.021446e-01 | 0.299 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.021446e-01 | 0.299 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.021446e-01 | 0.299 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.021446e-01 | 0.299 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.829381e-01 | 0.548 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.829381e-01 | 0.548 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.359290e-01 | 0.361 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.359290e-01 | 0.361 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.983475e-01 | 0.400 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.935895e-01 | 0.307 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.935895e-01 | 0.307 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.854329e-01 | 0.414 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.871351e-01 | 0.312 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.388358e-01 | 0.269 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.388358e-01 | 0.269 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.388358e-01 | 0.269 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.388358e-01 | 0.269 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.388358e-01 | 0.269 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.001858e-01 | 0.398 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.521087e-01 | 0.345 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.230291e-01 | 0.281 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.698771e-01 | 0.328 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.418543e-01 | 0.355 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.043738e-01 | 0.297 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.978533e-01 | 0.303 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.884043e-01 | 0.411 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.949582e-01 | 0.305 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.049900e-01 | 0.297 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.264723e-01 | 0.279 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.515033e-01 | 0.258 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.515033e-01 | 0.258 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.008950e-01 | 0.300 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.481262e-01 | 0.261 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.393434e-01 | 0.268 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.062099e-01 | 0.514 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.522875e-01 | 0.817 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.006547e-01 | 0.522 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.943169e-01 | 0.711 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.378872e-01 | 0.269 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.277653e-01 | 0.484 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.506392e-01 | 0.822 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.406167e-01 | 0.468 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.043738e-01 | 0.297 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.478943e-01 | 0.830 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.547313e-01 | 0.450 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.187897e-01 | 0.925 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.373713e-01 | 0.625 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.755515e-01 | 0.756 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.889484e-01 | 0.539 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.074647e-01 | 0.512 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.740446e-01 | 0.759 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.507548e-01 | 0.601 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.507548e-01 | 0.601 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.476278e-01 | 0.459 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 1.772319e-01 | 0.751 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.074647e-01 | 0.512 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.294532e-01 | 0.276 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.359290e-01 | 0.361 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.659093e-01 | 0.437 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.507548e-01 | 0.601 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.483615e-01 | 0.829 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.031862e-01 | 0.518 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.256366e-01 | 0.901 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.233857e-01 | 0.373 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.743566e-01 | 0.427 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.580994e-01 | 0.253 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.632722e-01 | 0.334 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.302775e-01 | 0.885 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.240999e-01 | 0.906 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.004641e-01 | 0.397 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.656009e-01 | 0.437 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.076870e-01 | 0.683 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.370256e-01 | 0.270 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.109503e-01 | 0.676 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.437422e-01 | 0.842 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.729753e-01 | 0.428 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.772319e-01 | 0.751 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.511696e-01 | 0.821 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.420082e-01 | 0.848 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.816430e-01 | 0.418 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.943169e-01 | 0.711 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.004641e-01 | 0.397 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.636176e-01 | 0.334 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.636176e-01 | 0.334 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.636176e-01 | 0.334 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.388358e-01 | 0.269 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.371058e-01 | 0.270 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.476159e-01 | 0.262 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.966982e-01 | 0.304 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.519606e-01 | 0.599 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.241369e-01 | 0.649 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.659093e-01 | 0.437 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.662131e-01 | 0.779 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.482207e-01 | 0.605 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.100016e-01 | 0.678 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.782337e-01 | 0.749 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.938967e-01 | 0.712 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.704154e-01 | 0.431 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.772319e-01 | 0.751 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.074780e-01 | 0.683 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.226653e-01 | 0.652 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.386611e-01 | 0.470 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.657187e-01 | 0.781 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.743613e-01 | 0.562 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.550969e-01 | 0.809 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.636176e-01 | 0.334 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.636176e-01 | 0.334 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.269600e-01 | 0.486 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.406167e-01 | 0.468 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.180144e-01 | 0.498 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.144188e-01 | 0.942 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.725086e-01 | 0.429 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.666211e-01 | 0.331 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.246407e-01 | 0.904 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.662131e-01 | 0.779 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.280867e-01 | 0.642 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.556356e-01 | 0.341 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.389764e-01 | 0.268 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.590443e-01 | 0.338 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.802224e-01 | 0.744 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.802224e-01 | 0.744 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.099767e-01 | 0.678 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.045819e-01 | 0.689 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.635047e-01 | 0.786 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.635047e-01 | 0.786 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.031862e-01 | 0.518 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.816430e-01 | 0.418 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.816430e-01 | 0.418 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.099767e-01 | 0.678 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.277653e-01 | 0.484 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.718790e-01 | 0.430 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.230291e-01 | 0.281 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.124145e-01 | 0.290 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.332536e-01 | 0.875 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.628262e-01 | 0.335 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.936507e-01 | 0.405 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.134424e-01 | 0.384 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.918966e-01 | 0.717 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.263792e-01 | 0.486 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.263792e-01 | 0.486 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.817309e-01 | 0.550 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.258228e-01 | 0.279 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.657187e-01 | 0.781 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.656009e-01 | 0.437 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.771587e-01 | 0.423 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.554689e-01 | 0.449 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.554689e-01 | 0.449 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.818796e-01 | 0.317 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.676077e-01 | 0.573 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.636241e-01 | 0.786 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.370840e-01 | 0.472 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.163293e-01 | 0.381 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.378872e-01 | 0.269 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.389547e-01 | 0.358 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.124145e-01 | 0.290 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.636995e-01 | 0.786 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.186951e-01 | 0.497 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.870103e-01 | 0.412 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.818796e-01 | 0.317 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.347670e-01 | 0.629 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.412521e-01 | 0.618 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.243015e-01 | 0.489 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.505565e-01 | 0.601 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.739724e-01 | 0.760 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.144188e-01 | 0.942 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.144188e-01 | 0.942 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.386611e-01 | 0.470 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.102765e-01 | 0.677 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.816430e-01 | 0.418 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.943169e-01 | 0.711 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.126004e-01 | 0.384 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.160606e-01 | 0.381 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.388358e-01 | 0.269 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.124145e-01 | 0.290 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.644366e-01 | 0.578 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.481262e-01 | 0.261 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.120426e-01 | 0.506 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.343223e-01 | 0.272 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.109503e-01 | 0.676 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.978533e-01 | 0.303 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.978533e-01 | 0.303 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.052937e-01 | 0.515 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.147668e-01 | 0.382 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.388336e-01 | 0.269 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.371058e-01 | 0.270 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.321863e-01 | 0.364 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.052937e-01 | 0.515 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.399892e-01 | 0.357 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.343223e-01 | 0.272 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.891724e-01 | 0.311 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.636695e-01 | 0.579 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.613543e-01 | 0.583 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.218482e-01 | 0.492 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.399892e-01 | 0.357 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.399892e-01 | 0.357 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.124145e-01 | 0.290 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.377759e-01 | 0.624 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.180320e-01 | 0.286 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.635047e-01 | 0.786 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.943169e-01 | 0.711 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.501215e-01 | 0.602 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.373713e-01 | 0.625 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.004641e-01 | 0.397 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.303949e-01 | 0.481 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.636176e-01 | 0.334 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.363420e-01 | 0.626 | 1 | 1 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.923314e-01 | 0.308 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.158645e-01 | 0.381 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.271368e-01 | 0.278 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.925530e-01 | 0.308 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.009272e-01 | 0.522 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.356308e-01 | 0.868 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.741673e-01 | 0.759 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.680608e-01 | 0.775 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.718790e-01 | 0.430 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.686471e-01 | 0.571 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.978533e-01 | 0.303 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.371058e-01 | 0.270 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.573571e-01 | 0.447 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.948058e-01 | 0.530 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 1.337175e-01 | 0.874 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.067541e-01 | 0.685 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.388358e-01 | 0.269 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.043738e-01 | 0.297 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.764804e-01 | 0.322 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.392400e-01 | 0.268 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.797716e-01 | 0.553 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.312861e-01 | 0.882 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.445030e-01 | 0.840 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.386611e-01 | 0.470 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.348343e-01 | 0.272 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.935895e-01 | 0.307 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.659093e-01 | 0.437 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.351013e-01 | 0.361 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.383389e-01 | 0.471 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.280228e-01 | 0.277 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.309325e-01 | 0.637 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.773914e-01 | 0.321 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.226046e-01 | 0.282 | 1 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.392400e-01 | 0.268 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.635047e-01 | 0.786 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.030798e-01 | 0.518 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.030798e-01 | 0.518 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.212195e-01 | 0.916 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.065295e-01 | 0.685 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.772319e-01 | 0.751 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.772319e-01 | 0.751 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 2.505565e-01 | 0.601 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.821199e-01 | 0.418 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.202490e-01 | 0.920 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.337175e-01 | 0.874 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.226653e-01 | 0.652 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.521998e-01 | 0.345 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.816430e-01 | 0.418 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.009272e-01 | 0.522 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.009272e-01 | 0.522 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.280867e-01 | 0.642 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.653011e-01 | 0.782 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.143349e-01 | 0.289 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.547313e-01 | 0.450 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.816904e-01 | 0.418 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.636176e-01 | 0.334 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.094254e-01 | 0.509 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.386227e-01 | 0.470 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.632722e-01 | 0.334 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.632722e-01 | 0.334 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.021446e-01 | 0.299 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.021446e-01 | 0.299 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.432986e-01 | 0.614 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.935895e-01 | 0.307 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.737820e-01 | 0.427 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.388358e-01 | 0.269 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.388358e-01 | 0.269 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.521087e-01 | 0.345 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.481262e-01 | 0.261 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.901355e-01 | 0.310 | 1 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.172758e-01 | 0.931 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.034729e-01 | 0.518 | 1 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.186951e-01 | 0.497 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.420924e-01 | 0.466 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.978533e-01 | 0.303 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.388358e-01 | 0.269 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.635650e-01 | 0.786 | 1 | 0 |
| Pexophagy | R-HSA-9664873 | 4.636176e-01 | 0.334 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.004983e-01 | 0.397 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.614273e-01 | 0.583 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.317008e-01 | 0.635 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.772319e-01 | 0.751 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.978600e-01 | 0.704 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.662131e-01 | 0.779 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.233857e-01 | 0.373 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.701981e-01 | 0.769 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.180320e-01 | 0.286 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.084204e-01 | 0.681 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.487210e-01 | 0.604 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.373713e-01 | 0.625 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.295794e-01 | 0.887 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.279878e-01 | 0.642 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.269970e-01 | 0.370 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.816430e-01 | 0.418 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.636176e-01 | 0.334 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.636176e-01 | 0.334 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.598226e-01 | 0.796 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.085182e-01 | 0.389 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.632722e-01 | 0.334 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.534161e-01 | 0.452 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.147668e-01 | 0.382 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.319441e-01 | 0.880 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 1.723938e-01 | 0.763 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.180593e-01 | 0.379 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.499206e-01 | 0.347 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.110146e-01 | 0.292 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.251887e-01 | 0.902 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.386611e-01 | 0.470 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.386611e-01 | 0.470 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.743613e-01 | 0.562 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.816430e-01 | 0.418 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.251887e-01 | 0.902 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.143349e-01 | 0.289 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.150622e-01 | 0.939 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.006547e-01 | 0.522 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.719726e-01 | 0.565 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.547313e-01 | 0.450 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.554689e-01 | 0.449 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.772319e-01 | 0.751 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.552942e-01 | 0.809 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.050104e-01 | 0.688 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.126004e-01 | 0.384 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.147668e-01 | 0.382 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.342414e-01 | 0.362 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.043738e-01 | 0.297 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.955023e-01 | 0.529 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.719726e-01 | 0.565 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.607479e-01 | 0.584 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.889484e-01 | 0.539 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 2.150207e-01 | 0.668 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.497069e-01 | 0.347 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.346928e-01 | 0.362 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.802224e-01 | 0.744 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.935895e-01 | 0.307 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.100016e-01 | 0.678 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.030798e-01 | 0.518 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.505565e-01 | 0.601 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.821199e-01 | 0.418 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.074780e-01 | 0.683 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.521998e-01 | 0.345 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.031862e-01 | 0.518 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.143349e-01 | 0.289 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.632722e-01 | 0.334 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.021446e-01 | 0.299 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.935895e-01 | 0.307 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.503944e-01 | 0.455 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 5.371058e-01 | 0.270 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.091379e-01 | 0.510 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.377759e-01 | 0.624 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.256647e-01 | 0.647 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.410223e-01 | 0.267 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.978600e-01 | 0.704 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.726112e-01 | 0.564 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.359290e-01 | 0.361 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.387609e-01 | 0.622 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.521998e-01 | 0.345 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.456768e-01 | 0.610 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.636176e-01 | 0.334 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.799008e-01 | 0.420 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.935895e-01 | 0.307 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.269600e-01 | 0.486 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.826794e-01 | 0.417 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.514019e-01 | 0.454 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.483615e-01 | 0.829 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.772319e-01 | 0.751 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.505565e-01 | 0.601 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.386611e-01 | 0.470 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.386611e-01 | 0.470 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.816430e-01 | 0.418 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.188906e-01 | 0.660 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.984759e-01 | 0.400 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.604418e-01 | 0.337 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.006547e-01 | 0.522 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.918966e-01 | 0.717 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.910365e-01 | 0.536 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.124145e-01 | 0.290 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.067541e-01 | 0.685 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.743613e-01 | 0.562 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.351013e-01 | 0.361 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.233857e-01 | 0.373 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.817425e-01 | 0.741 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.388358e-01 | 0.269 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.495378e-01 | 0.603 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.725086e-01 | 0.429 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.762320e-01 | 0.754 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.021446e-01 | 0.299 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.542557e-01 | 0.812 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.542557e-01 | 0.812 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.515033e-01 | 0.258 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.154663e-01 | 0.501 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.636176e-01 | 0.334 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.867204e-01 | 0.313 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.583684e-01 | 0.253 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.611497e-01 | 0.251 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.638534e-01 | 0.249 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.641131e-01 | 0.249 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.692925e-01 | 0.245 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.692925e-01 | 0.245 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.694255e-01 | 0.245 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.694255e-01 | 0.245 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.694255e-01 | 0.245 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.694255e-01 | 0.245 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.694255e-01 | 0.245 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.694255e-01 | 0.245 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.694255e-01 | 0.245 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.694255e-01 | 0.245 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.694255e-01 | 0.245 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.694255e-01 | 0.245 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.698289e-01 | 0.244 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.698289e-01 | 0.244 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.736121e-01 | 0.241 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.736121e-01 | 0.241 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.736121e-01 | 0.241 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.736121e-01 | 0.241 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.736121e-01 | 0.241 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.736121e-01 | 0.241 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.736121e-01 | 0.241 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.736121e-01 | 0.241 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.757495e-01 | 0.240 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.764853e-01 | 0.239 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.785013e-01 | 0.238 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.789439e-01 | 0.237 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.789439e-01 | 0.237 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.789439e-01 | 0.237 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.830029e-01 | 0.234 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.830029e-01 | 0.234 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.844966e-01 | 0.233 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.886185e-01 | 0.230 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.890061e-01 | 0.230 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.899342e-01 | 0.229 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.899342e-01 | 0.229 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.945994e-01 | 0.226 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.951666e-01 | 0.225 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.951666e-01 | 0.225 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.961774e-01 | 0.225 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.001782e-01 | 0.222 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.053001e-01 | 0.218 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.053001e-01 | 0.218 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.053001e-01 | 0.218 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.053001e-01 | 0.218 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.053001e-01 | 0.218 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.064358e-01 | 0.217 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.064358e-01 | 0.217 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.064358e-01 | 0.217 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.064358e-01 | 0.217 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.064358e-01 | 0.217 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.064358e-01 | 0.217 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.064358e-01 | 0.217 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.064358e-01 | 0.217 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.064358e-01 | 0.217 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.064358e-01 | 0.217 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.064358e-01 | 0.217 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.064358e-01 | 0.217 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 6.064358e-01 | 0.217 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.064358e-01 | 0.217 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.064358e-01 | 0.217 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.064358e-01 | 0.217 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.071059e-01 | 0.217 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.071059e-01 | 0.217 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.071059e-01 | 0.217 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.095767e-01 | 0.215 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.095767e-01 | 0.215 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.100194e-01 | 0.215 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 6.100194e-01 | 0.215 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.182698e-01 | 0.209 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.182698e-01 | 0.209 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.182698e-01 | 0.209 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.182698e-01 | 0.209 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.182698e-01 | 0.209 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.182698e-01 | 0.209 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.182698e-01 | 0.209 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 6.182698e-01 | 0.209 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.182698e-01 | 0.209 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.182698e-01 | 0.209 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.182698e-01 | 0.209 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.182698e-01 | 0.209 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.182698e-01 | 0.209 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.182698e-01 | 0.209 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.182698e-01 | 0.209 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.182698e-01 | 0.209 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.182698e-01 | 0.209 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.182698e-01 | 0.209 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.206249e-01 | 0.207 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.278815e-01 | 0.202 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.295219e-01 | 0.201 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.301430e-01 | 0.201 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.301430e-01 | 0.201 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.305368e-01 | 0.200 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.305368e-01 | 0.200 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.305368e-01 | 0.200 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.305368e-01 | 0.200 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.311674e-01 | 0.200 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.359360e-01 | 0.197 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.359360e-01 | 0.197 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.373023e-01 | 0.196 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.373023e-01 | 0.196 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 6.373023e-01 | 0.196 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 6.373023e-01 | 0.196 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 6.373023e-01 | 0.196 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.373023e-01 | 0.196 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 6.373023e-01 | 0.196 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.373023e-01 | 0.196 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.373023e-01 | 0.196 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.388633e-01 | 0.195 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.443901e-01 | 0.191 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.484201e-01 | 0.188 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.484201e-01 | 0.188 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.484201e-01 | 0.188 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.484469e-01 | 0.188 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.493915e-01 | 0.187 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.499917e-01 | 0.187 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.508965e-01 | 0.186 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.509456e-01 | 0.186 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.527573e-01 | 0.185 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.546325e-01 | 0.184 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.546325e-01 | 0.184 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.546325e-01 | 0.184 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.546325e-01 | 0.184 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.548492e-01 | 0.184 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.570927e-01 | 0.182 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.594348e-01 | 0.181 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.615758e-01 | 0.179 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.615758e-01 | 0.179 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.615758e-01 | 0.179 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.615758e-01 | 0.179 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.615758e-01 | 0.179 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.615758e-01 | 0.179 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.615758e-01 | 0.179 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.615758e-01 | 0.179 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.649731e-01 | 0.177 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.649731e-01 | 0.177 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.662333e-01 | 0.176 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.662333e-01 | 0.176 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.662333e-01 | 0.176 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.662333e-01 | 0.176 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.662333e-01 | 0.176 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.662333e-01 | 0.176 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.662333e-01 | 0.176 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.662333e-01 | 0.176 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.662333e-01 | 0.176 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.662333e-01 | 0.176 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.665285e-01 | 0.176 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.665285e-01 | 0.176 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.666972e-01 | 0.176 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.666972e-01 | 0.176 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.669201e-01 | 0.176 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.679116e-01 | 0.175 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.702270e-01 | 0.174 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.702270e-01 | 0.174 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.756235e-01 | 0.170 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.775779e-01 | 0.169 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.775779e-01 | 0.169 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.775779e-01 | 0.169 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.799728e-01 | 0.168 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.799728e-01 | 0.168 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.814884e-01 | 0.167 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.814884e-01 | 0.167 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.814884e-01 | 0.167 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.814884e-01 | 0.167 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.817208e-01 | 0.166 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.837476e-01 | 0.165 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.847477e-01 | 0.164 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.896413e-01 | 0.161 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.896413e-01 | 0.161 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.896413e-01 | 0.161 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.896413e-01 | 0.161 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.932705e-01 | 0.159 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.932705e-01 | 0.159 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.932705e-01 | 0.159 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.932705e-01 | 0.159 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.932705e-01 | 0.159 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.932705e-01 | 0.159 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.932705e-01 | 0.159 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.932705e-01 | 0.159 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.932705e-01 | 0.159 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.932705e-01 | 0.159 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.932705e-01 | 0.159 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.932705e-01 | 0.159 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.944166e-01 | 0.158 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.948329e-01 | 0.158 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.948329e-01 | 0.158 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.991871e-01 | 0.155 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.993738e-01 | 0.155 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 6.993738e-01 | 0.155 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.993738e-01 | 0.155 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.993738e-01 | 0.155 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.999710e-01 | 0.155 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.999710e-01 | 0.155 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.999710e-01 | 0.155 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.999710e-01 | 0.155 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.999710e-01 | 0.155 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.999710e-01 | 0.155 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.999710e-01 | 0.155 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.999710e-01 | 0.155 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.999710e-01 | 0.155 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.999710e-01 | 0.155 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.999710e-01 | 0.155 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.999710e-01 | 0.155 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.999710e-01 | 0.155 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.999710e-01 | 0.155 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.999710e-01 | 0.155 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.999710e-01 | 0.155 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 6.999710e-01 | 0.155 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.999710e-01 | 0.155 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.999710e-01 | 0.155 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.013427e-01 | 0.154 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.013427e-01 | 0.154 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.013427e-01 | 0.154 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.028193e-01 | 0.153 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.047607e-01 | 0.152 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.052711e-01 | 0.152 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.055820e-01 | 0.151 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.057934e-01 | 0.151 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.058526e-01 | 0.151 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.079576e-01 | 0.150 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.082300e-01 | 0.150 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.090956e-01 | 0.149 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.124412e-01 | 0.147 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.129870e-01 | 0.147 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.166295e-01 | 0.145 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.176982e-01 | 0.144 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.176982e-01 | 0.144 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.176982e-01 | 0.144 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.184713e-01 | 0.144 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.184713e-01 | 0.144 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.184713e-01 | 0.144 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.184713e-01 | 0.144 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.184713e-01 | 0.144 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.184713e-01 | 0.144 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 7.184713e-01 | 0.144 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.184713e-01 | 0.144 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.184713e-01 | 0.144 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.200302e-01 | 0.143 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.200302e-01 | 0.143 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.200302e-01 | 0.143 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.200302e-01 | 0.143 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.200302e-01 | 0.143 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.200962e-01 | 0.143 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.229067e-01 | 0.141 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.277052e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.303526e-01 | 0.136 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.334060e-01 | 0.135 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.340123e-01 | 0.134 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.340123e-01 | 0.134 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.340123e-01 | 0.134 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.340123e-01 | 0.134 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.340123e-01 | 0.134 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.340123e-01 | 0.134 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.340123e-01 | 0.134 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.340123e-01 | 0.134 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.340123e-01 | 0.134 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.340123e-01 | 0.134 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.373941e-01 | 0.132 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.395644e-01 | 0.131 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.395644e-01 | 0.131 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.395644e-01 | 0.131 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.399952e-01 | 0.131 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.419043e-01 | 0.130 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.419043e-01 | 0.130 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.476633e-01 | 0.126 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.484680e-01 | 0.126 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.491639e-01 | 0.125 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.491639e-01 | 0.125 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.546171e-01 | 0.122 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.569248e-01 | 0.121 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.575268e-01 | 0.121 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.580000e-01 | 0.120 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.590732e-01 | 0.120 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.590732e-01 | 0.120 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.616093e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.628890e-01 | 0.118 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.628890e-01 | 0.118 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.628890e-01 | 0.118 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.636461e-01 | 0.117 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.636461e-01 | 0.117 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.636461e-01 | 0.117 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.636461e-01 | 0.117 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.636461e-01 | 0.117 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.636461e-01 | 0.117 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.636461e-01 | 0.117 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.641929e-01 | 0.117 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.641929e-01 | 0.117 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.641929e-01 | 0.117 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.641929e-01 | 0.117 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.641929e-01 | 0.117 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.641929e-01 | 0.117 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 7.641929e-01 | 0.117 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.641929e-01 | 0.117 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.641929e-01 | 0.117 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.641929e-01 | 0.117 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.641929e-01 | 0.117 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.641929e-01 | 0.117 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.641929e-01 | 0.117 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.671249e-01 | 0.115 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.744111e-01 | 0.111 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.749898e-01 | 0.111 | 1 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.753657e-01 | 0.110 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.766760e-01 | 0.110 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.766760e-01 | 0.110 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.766760e-01 | 0.110 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.766760e-01 | 0.110 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.778691e-01 | 0.109 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.794911e-01 | 0.108 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.805088e-01 | 0.108 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.831267e-01 | 0.106 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.831267e-01 | 0.106 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.837787e-01 | 0.106 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.837787e-01 | 0.106 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.837787e-01 | 0.106 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.837787e-01 | 0.106 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.837787e-01 | 0.106 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.858895e-01 | 0.105 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.881184e-01 | 0.103 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.889684e-01 | 0.103 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.898385e-01 | 0.102 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.898385e-01 | 0.102 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.909507e-01 | 0.102 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.909507e-01 | 0.102 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.909507e-01 | 0.102 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.909507e-01 | 0.102 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.909507e-01 | 0.102 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.909507e-01 | 0.102 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.909507e-01 | 0.102 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.909507e-01 | 0.102 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.909507e-01 | 0.102 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.909507e-01 | 0.102 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.909507e-01 | 0.102 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.909507e-01 | 0.102 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.916943e-01 | 0.101 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.941109e-01 | 0.100 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.982608e-01 | 0.098 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.023874e-01 | 0.096 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.023874e-01 | 0.096 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.023874e-01 | 0.096 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.023874e-01 | 0.096 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.023874e-01 | 0.096 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.023874e-01 | 0.096 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.023877e-01 | 0.096 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.027638e-01 | 0.095 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.027638e-01 | 0.095 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.059519e-01 | 0.094 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.070219e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.070219e-01 | 0.093 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.070219e-01 | 0.093 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.070219e-01 | 0.093 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.086205e-01 | 0.092 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.144429e-01 | 0.089 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.144429e-01 | 0.089 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.146735e-01 | 0.089 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.146735e-01 | 0.089 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.146735e-01 | 0.089 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.146735e-01 | 0.089 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.146735e-01 | 0.089 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.146735e-01 | 0.089 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.146735e-01 | 0.089 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.146735e-01 | 0.089 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.146735e-01 | 0.089 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.146735e-01 | 0.089 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.150797e-01 | 0.089 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.150797e-01 | 0.089 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.158181e-01 | 0.088 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.184209e-01 | 0.087 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.195586e-01 | 0.086 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.195586e-01 | 0.086 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.197355e-01 | 0.086 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.199376e-01 | 0.086 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.213869e-01 | 0.085 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.213869e-01 | 0.085 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.226535e-01 | 0.085 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.256030e-01 | 0.083 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.256030e-01 | 0.083 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.256030e-01 | 0.083 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.256030e-01 | 0.083 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.256030e-01 | 0.083 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.256030e-01 | 0.083 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.269141e-01 | 0.083 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.353790e-01 | 0.078 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.353790e-01 | 0.078 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.353790e-01 | 0.078 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.353790e-01 | 0.078 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.353790e-01 | 0.078 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.357055e-01 | 0.078 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.357055e-01 | 0.078 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.357055e-01 | 0.078 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.357055e-01 | 0.078 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.357055e-01 | 0.078 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.357055e-01 | 0.078 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.357055e-01 | 0.078 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.357055e-01 | 0.078 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.357055e-01 | 0.078 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.362929e-01 | 0.078 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.397951e-01 | 0.076 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.401144e-01 | 0.076 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.421980e-01 | 0.075 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.452135e-01 | 0.073 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.456381e-01 | 0.073 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.459403e-01 | 0.073 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.467306e-01 | 0.072 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.473906e-01 | 0.072 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.499338e-01 | 0.071 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.499338e-01 | 0.071 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.499338e-01 | 0.071 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.499338e-01 | 0.071 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.499338e-01 | 0.071 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.499338e-01 | 0.071 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.538341e-01 | 0.069 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.543518e-01 | 0.068 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.543518e-01 | 0.068 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.543518e-01 | 0.068 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.543518e-01 | 0.068 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.543518e-01 | 0.068 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.543518e-01 | 0.068 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.543518e-01 | 0.068 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.543518e-01 | 0.068 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.543518e-01 | 0.068 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.543518e-01 | 0.068 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.591125e-01 | 0.066 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.591125e-01 | 0.066 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.591125e-01 | 0.066 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.633066e-01 | 0.064 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.633066e-01 | 0.064 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.633066e-01 | 0.064 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.656167e-01 | 0.063 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.656167e-01 | 0.063 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.672071e-01 | 0.062 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.698200e-01 | 0.061 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.700369e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.700369e-01 | 0.060 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.700369e-01 | 0.060 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.708828e-01 | 0.060 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.708828e-01 | 0.060 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.708828e-01 | 0.060 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.708828e-01 | 0.060 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.708828e-01 | 0.060 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.708828e-01 | 0.060 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.708828e-01 | 0.060 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.708828e-01 | 0.060 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.708828e-01 | 0.060 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.708828e-01 | 0.060 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.708828e-01 | 0.060 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.711268e-01 | 0.060 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.743006e-01 | 0.058 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.755780e-01 | 0.058 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.755780e-01 | 0.058 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.825032e-01 | 0.054 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.830330e-01 | 0.054 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.830330e-01 | 0.054 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.833698e-01 | 0.054 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.833698e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.855384e-01 | 0.053 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.855384e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.855384e-01 | 0.053 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.855384e-01 | 0.053 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.855384e-01 | 0.053 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.855384e-01 | 0.053 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.855384e-01 | 0.053 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.855384e-01 | 0.053 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.855384e-01 | 0.053 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.855384e-01 | 0.053 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.855384e-01 | 0.053 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.855384e-01 | 0.053 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.855384e-01 | 0.053 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.855384e-01 | 0.053 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.868258e-01 | 0.052 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.884798e-01 | 0.051 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.896602e-01 | 0.051 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.896602e-01 | 0.051 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.896602e-01 | 0.051 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.896602e-01 | 0.051 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.896602e-01 | 0.051 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.964970e-01 | 0.047 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.971241e-01 | 0.047 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.971241e-01 | 0.047 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.971241e-01 | 0.047 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.971241e-01 | 0.047 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.975405e-01 | 0.047 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.984405e-01 | 0.047 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.985313e-01 | 0.046 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.985313e-01 | 0.046 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.985313e-01 | 0.046 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.985313e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.985313e-01 | 0.046 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.985313e-01 | 0.046 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.985313e-01 | 0.046 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.985313e-01 | 0.046 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.985313e-01 | 0.046 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.985313e-01 | 0.046 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.985313e-01 | 0.046 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.985313e-01 | 0.046 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.985313e-01 | 0.046 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.006299e-01 | 0.045 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.013961e-01 | 0.045 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.035662e-01 | 0.044 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.036877e-01 | 0.044 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.040024e-01 | 0.044 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.044131e-01 | 0.044 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.058063e-01 | 0.043 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.065436e-01 | 0.043 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.065436e-01 | 0.043 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.065436e-01 | 0.043 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.065436e-01 | 0.043 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.065862e-01 | 0.043 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.065862e-01 | 0.043 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.066045e-01 | 0.043 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.068427e-01 | 0.042 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.100500e-01 | 0.041 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.100500e-01 | 0.041 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.100500e-01 | 0.041 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.100500e-01 | 0.041 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.100500e-01 | 0.041 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.100500e-01 | 0.041 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.100500e-01 | 0.041 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.100500e-01 | 0.041 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.108801e-01 | 0.041 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.108801e-01 | 0.041 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.141354e-01 | 0.039 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.151511e-01 | 0.039 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.151511e-01 | 0.039 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.151511e-01 | 0.039 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.151511e-01 | 0.039 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.177285e-01 | 0.037 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.193962e-01 | 0.036 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.202616e-01 | 0.036 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.202616e-01 | 0.036 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.202616e-01 | 0.036 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.202616e-01 | 0.036 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.202616e-01 | 0.036 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.202616e-01 | 0.036 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.202616e-01 | 0.036 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.211250e-01 | 0.036 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.211250e-01 | 0.036 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.211250e-01 | 0.036 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.211250e-01 | 0.036 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.226711e-01 | 0.035 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.230093e-01 | 0.035 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.270628e-01 | 0.033 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.275904e-01 | 0.033 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.293146e-01 | 0.032 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.293146e-01 | 0.032 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.293146e-01 | 0.032 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.293146e-01 | 0.032 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.293146e-01 | 0.032 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.293146e-01 | 0.032 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.293146e-01 | 0.032 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.293146e-01 | 0.032 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.293146e-01 | 0.032 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.293146e-01 | 0.032 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.294138e-01 | 0.032 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.294138e-01 | 0.032 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.301776e-01 | 0.031 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.301776e-01 | 0.031 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.301776e-01 | 0.031 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.313755e-01 | 0.031 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.335656e-01 | 0.030 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.347353e-01 | 0.029 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.347353e-01 | 0.029 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.367111e-01 | 0.028 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.367111e-01 | 0.028 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.367111e-01 | 0.028 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.367111e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.373401e-01 | 0.028 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.373401e-01 | 0.028 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.373401e-01 | 0.028 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.373401e-01 | 0.028 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.374195e-01 | 0.028 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.374622e-01 | 0.028 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.375719e-01 | 0.028 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.375719e-01 | 0.028 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.375719e-01 | 0.028 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.407211e-01 | 0.027 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.410137e-01 | 0.026 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.421788e-01 | 0.026 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.429457e-01 | 0.026 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.434899e-01 | 0.025 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.441736e-01 | 0.025 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.443002e-01 | 0.025 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.443002e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.444549e-01 | 0.025 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.444549e-01 | 0.025 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.444549e-01 | 0.025 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.444549e-01 | 0.025 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.444549e-01 | 0.025 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.444549e-01 | 0.025 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.444549e-01 | 0.025 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.455063e-01 | 0.024 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.455063e-01 | 0.024 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.480773e-01 | 0.023 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.489654e-01 | 0.023 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.507622e-01 | 0.022 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.507622e-01 | 0.022 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.507622e-01 | 0.022 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.507622e-01 | 0.022 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.507622e-01 | 0.022 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.507622e-01 | 0.022 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.507622e-01 | 0.022 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.507622e-01 | 0.022 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.530029e-01 | 0.021 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.531897e-01 | 0.021 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.531897e-01 | 0.021 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.531897e-01 | 0.021 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.539945e-01 | 0.020 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.539945e-01 | 0.020 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.552050e-01 | 0.020 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.562626e-01 | 0.019 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.563536e-01 | 0.019 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.563536e-01 | 0.019 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.563536e-01 | 0.019 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.563536e-01 | 0.019 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.563536e-01 | 0.019 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.563536e-01 | 0.019 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.563536e-01 | 0.019 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.563536e-01 | 0.019 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.563536e-01 | 0.019 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.563536e-01 | 0.019 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.563536e-01 | 0.019 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.571333e-01 | 0.019 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.571692e-01 | 0.019 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.571692e-01 | 0.019 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.574797e-01 | 0.019 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.574797e-01 | 0.019 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.574797e-01 | 0.019 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.574797e-01 | 0.019 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.574797e-01 | 0.019 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.574797e-01 | 0.019 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.585849e-01 | 0.018 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.599413e-01 | 0.018 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.611777e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.613104e-01 | 0.017 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.613104e-01 | 0.017 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.613104e-01 | 0.017 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.613104e-01 | 0.017 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.613104e-01 | 0.017 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.615461e-01 | 0.017 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.615461e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.615461e-01 | 0.017 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.636766e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.641948e-01 | 0.016 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.657045e-01 | 0.015 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.657045e-01 | 0.015 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.657045e-01 | 0.015 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.657045e-01 | 0.015 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.657045e-01 | 0.015 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.657045e-01 | 0.015 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.657045e-01 | 0.015 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.658123e-01 | 0.015 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.662600e-01 | 0.015 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.672771e-01 | 0.014 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.672861e-01 | 0.014 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.685871e-01 | 0.014 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.685871e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.685871e-01 | 0.014 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.685871e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.695997e-01 | 0.013 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.695997e-01 | 0.013 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.695997e-01 | 0.013 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.695997e-01 | 0.013 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.695997e-01 | 0.013 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.698515e-01 | 0.013 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.701240e-01 | 0.013 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.710675e-01 | 0.013 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.710675e-01 | 0.013 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.716243e-01 | 0.013 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.720522e-01 | 0.012 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.727278e-01 | 0.012 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.727278e-01 | 0.012 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.730528e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.730528e-01 | 0.012 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.730528e-01 | 0.012 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.730528e-01 | 0.012 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.743771e-01 | 0.011 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.743771e-01 | 0.011 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.743771e-01 | 0.011 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.743771e-01 | 0.011 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.750765e-01 | 0.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.755445e-01 | 0.011 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.761138e-01 | 0.010 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.761138e-01 | 0.010 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.761138e-01 | 0.010 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.761138e-01 | 0.010 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.761138e-01 | 0.010 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.761138e-01 | 0.010 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.761138e-01 | 0.010 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.761138e-01 | 0.010 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.761138e-01 | 0.010 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.761138e-01 | 0.010 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.761138e-01 | 0.010 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.768708e-01 | 0.010 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.768708e-01 | 0.010 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.771718e-01 | 0.010 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.773033e-01 | 0.010 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.788272e-01 | 0.009 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.788272e-01 | 0.009 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.788272e-01 | 0.009 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.788272e-01 | 0.009 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.788272e-01 | 0.009 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.788272e-01 | 0.009 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.788272e-01 | 0.009 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.791288e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.791288e-01 | 0.009 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.791288e-01 | 0.009 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.791288e-01 | 0.009 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.792687e-01 | 0.009 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.793698e-01 | 0.009 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.793704e-01 | 0.009 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.793852e-01 | 0.009 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.794213e-01 | 0.009 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.798733e-01 | 0.009 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.798733e-01 | 0.009 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.803750e-01 | 0.009 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.811419e-01 | 0.008 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.812326e-01 | 0.008 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.812326e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.812326e-01 | 0.008 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.812326e-01 | 0.008 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.812326e-01 | 0.008 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.812326e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.812326e-01 | 0.008 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.812326e-01 | 0.008 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.815160e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.828204e-01 | 0.008 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.830213e-01 | 0.007 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.831516e-01 | 0.007 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.833648e-01 | 0.007 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.833648e-01 | 0.007 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.833648e-01 | 0.007 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.843553e-01 | 0.007 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.845830e-01 | 0.007 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.846033e-01 | 0.007 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.846127e-01 | 0.007 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.846932e-01 | 0.007 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.852549e-01 | 0.006 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.852549e-01 | 0.006 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.852549e-01 | 0.006 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.852549e-01 | 0.006 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.862045e-01 | 0.006 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.862045e-01 | 0.006 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.862045e-01 | 0.006 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.862045e-01 | 0.006 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.862183e-01 | 0.006 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.869303e-01 | 0.006 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.870071e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.870402e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.870402e-01 | 0.006 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.875701e-01 | 0.005 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.875701e-01 | 0.005 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.875701e-01 | 0.005 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.875701e-01 | 0.005 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.875701e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.879623e-01 | 0.005 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.882108e-01 | 0.005 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.884154e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.884154e-01 | 0.005 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.884154e-01 | 0.005 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.884154e-01 | 0.005 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.887683e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.889932e-01 | 0.005 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.892792e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.892792e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.892792e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.893767e-01 | 0.005 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.897179e-01 | 0.004 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.897319e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.908988e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.908988e-01 | 0.004 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.917121e-01 | 0.004 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.919332e-01 | 0.004 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.919332e-01 | 0.004 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.919332e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.921278e-01 | 0.003 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.925577e-01 | 0.003 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.926480e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.928031e-01 | 0.003 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.928501e-01 | 0.003 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.928501e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.928501e-01 | 0.003 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.928501e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.928501e-01 | 0.003 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.928501e-01 | 0.003 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.928501e-01 | 0.003 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.933858e-01 | 0.003 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.936628e-01 | 0.003 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.936628e-01 | 0.003 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.936628e-01 | 0.003 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.936628e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.936628e-01 | 0.003 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.936628e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.936628e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.939776e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.939776e-01 | 0.003 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.940510e-01 | 0.003 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.941605e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.943831e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.945353e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.946792e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.947139e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.950217e-01 | 0.002 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.950217e-01 | 0.002 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.950217e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.950217e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.950217e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.950217e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.950217e-01 | 0.002 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.952463e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.955041e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.955876e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.959238e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.959238e-01 | 0.002 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.960893e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.960893e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.960893e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.961150e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.964274e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.965094e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.965269e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.965339e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.965339e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.965339e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.966410e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.967702e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.969280e-01 | 0.001 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.972774e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.972774e-01 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.975870e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.975870e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.978614e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.979615e-01 | 0.001 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.979618e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.983202e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.984277e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.985024e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.986806e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.988149e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.988420e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.989372e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.989637e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.989637e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.990816e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.991861e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.991861e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.992341e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.992341e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.993136e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.993320e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.994244e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.995259e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.995414e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.995551e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.996828e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.997257e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.997257e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.997257e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997362e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.997453e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997603e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997603e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997833e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998053e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998091e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998091e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998169e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998245e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998501e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998823e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998918e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999181e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999275e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999357e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999430e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999430e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999447e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999465e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999553e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999553e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999562e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999609e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999685e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999689e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999724e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999784e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999785e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999799e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999822e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999849e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999856e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999866e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999875e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999895e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999905e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999907e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999941e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999949e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999952e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999953e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999965e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999969e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999983e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999984e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999984e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.220446e-16 | 15.654 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.998401e-15 | 14.699 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.103829e-15 | 14.041 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.708145e-14 | 13.431 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.329870e-14 | 13.364 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.421419e-12 | 11.847 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.748046e-12 | 11.757 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.076029e-12 | 11.216 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.048251e-11 | 10.516 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.987388e-11 | 10.302 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.153700e-10 | 9.938 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.070693e-10 | 9.684 | 1 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.002698e-10 | 9.222 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.160060e-09 | 8.936 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.266773e-09 | 8.897 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.523504e-09 | 8.817 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.692100e-09 | 8.772 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.954214e-09 | 8.709 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.729202e-09 | 8.172 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.103469e-08 | 7.677 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.482602e-08 | 7.458 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.994950e-08 | 7.398 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.239688e-08 | 7.373 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.247915e-08 | 7.280 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.550219e-08 | 7.184 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.760225e-08 | 7.170 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.760225e-08 | 7.170 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.082936e-07 | 6.965 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.383418e-07 | 6.859 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.365081e-07 | 6.865 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.478804e-07 | 6.830 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.439798e-07 | 6.613 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.460936e-07 | 6.609 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.798242e-07 | 6.553 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.798242e-07 | 6.553 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.958047e-07 | 6.529 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.824416e-07 | 6.417 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.527453e-07 | 6.257 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.895229e-07 | 6.229 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.227943e-07 | 6.206 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.637722e-07 | 6.064 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.091786e-07 | 6.041 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.425354e-07 | 6.026 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.683900e-06 | 5.774 | 1 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.740756e-06 | 5.759 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.822965e-06 | 5.739 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.954698e-06 | 5.709 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.987633e-06 | 5.702 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.102753e-06 | 5.677 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.221883e-06 | 5.653 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.317518e-06 | 5.635 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.457065e-06 | 5.610 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.674318e-06 | 5.573 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.486596e-06 | 5.458 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.369215e-06 | 5.360 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.369215e-06 | 5.360 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.063206e-06 | 5.296 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.544208e-06 | 5.256 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.599393e-06 | 5.252 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.264953e-06 | 5.203 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.796161e-06 | 5.009 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.065308e-05 | 4.973 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.078902e-05 | 4.967 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.098616e-05 | 4.959 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.106299e-05 | 4.956 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.169908e-05 | 4.932 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.369548e-05 | 4.863 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.512565e-05 | 4.820 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.864073e-05 | 4.730 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.524674e-05 | 4.598 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.681530e-05 | 4.572 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.814448e-05 | 4.551 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.760146e-05 | 4.559 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.853237e-05 | 4.545 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.859877e-05 | 4.544 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.459923e-05 | 4.461 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.539303e-05 | 4.451 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.768201e-05 | 4.424 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.152107e-05 | 4.382 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.183644e-05 | 4.378 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.505124e-05 | 4.346 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.540758e-05 | 4.343 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.594661e-05 | 4.338 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.868025e-05 | 4.313 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.053123e-05 | 4.296 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.224287e-05 | 4.282 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.305535e-05 | 4.275 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.305535e-05 | 4.275 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.305535e-05 | 4.275 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.600252e-05 | 4.252 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.621511e-05 | 4.250 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.032471e-05 | 4.220 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.143022e-05 | 4.212 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.213313e-05 | 4.207 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.213313e-05 | 4.207 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.141270e-05 | 4.146 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.016042e-05 | 4.096 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.881495e-05 | 4.052 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.147231e-05 | 4.039 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 9.605323e-05 | 4.017 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.580181e-05 | 4.019 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.863757e-05 | 4.006 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.863757e-05 | 4.006 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.579461e-05 | 4.019 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.726979e-05 | 4.012 | 1 | 1 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.069442e-04 | 3.971 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.108162e-04 | 3.955 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.121552e-04 | 3.950 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.247638e-04 | 3.904 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.335663e-04 | 3.874 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.422712e-04 | 3.847 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.504757e-04 | 3.823 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.569128e-04 | 3.804 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.586623e-04 | 3.800 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.611637e-04 | 3.793 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.611637e-04 | 3.793 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.871896e-04 | 3.728 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.882256e-04 | 3.725 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.138696e-04 | 3.670 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.179307e-04 | 3.662 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.248541e-04 | 3.648 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.636312e-04 | 3.579 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.543321e-04 | 3.595 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.500519e-04 | 3.602 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.656853e-04 | 3.576 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.656853e-04 | 3.576 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.720767e-04 | 3.565 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.720767e-04 | 3.565 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.777661e-04 | 3.556 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.833791e-04 | 3.548 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.872393e-04 | 3.542 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.147862e-04 | 3.502 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.973836e-04 | 3.527 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.973836e-04 | 3.527 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.037910e-04 | 3.517 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 3.191854e-04 | 3.496 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.528402e-04 | 3.452 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.528402e-04 | 3.452 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.805492e-04 | 3.420 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.927341e-04 | 3.406 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.947107e-04 | 3.404 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.947107e-04 | 3.404 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.089623e-04 | 3.388 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.444744e-04 | 3.352 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.191824e-04 | 3.378 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.333161e-04 | 3.363 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.383522e-04 | 3.358 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.444744e-04 | 3.352 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.641743e-04 | 3.333 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.763030e-04 | 3.322 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.920438e-04 | 3.308 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.923597e-04 | 3.308 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.000805e-04 | 3.301 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.000805e-04 | 3.301 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.000805e-04 | 3.301 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.083572e-04 | 3.294 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.211658e-04 | 3.283 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.718375e-04 | 3.243 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.121715e-04 | 3.213 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.710568e-04 | 3.243 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.642967e-04 | 3.248 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.121715e-04 | 3.213 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.088324e-04 | 3.216 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.766884e-04 | 3.239 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.705320e-04 | 3.244 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.183158e-04 | 3.209 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.405062e-04 | 3.193 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.712970e-04 | 3.173 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.712970e-04 | 3.173 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.712970e-04 | 3.173 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.936621e-04 | 3.159 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.249322e-04 | 3.140 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.249322e-04 | 3.140 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.249322e-04 | 3.140 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.249322e-04 | 3.140 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.617135e-04 | 3.065 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.724512e-04 | 3.059 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.918245e-04 | 3.050 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.053235e-03 | 2.977 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.479719e-04 | 3.023 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.407023e-04 | 3.027 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.489156e-04 | 3.023 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.101012e-03 | 2.958 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.101012e-03 | 2.958 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.106915e-03 | 2.956 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.106915e-03 | 2.956 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.106915e-03 | 2.956 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.106915e-03 | 2.956 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.125951e-03 | 2.948 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.203269e-03 | 2.920 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.224390e-03 | 2.912 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.224390e-03 | 2.912 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.249799e-03 | 2.903 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.254397e-03 | 2.902 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.291706e-03 | 2.889 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.434715e-03 | 2.843 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.565167e-03 | 2.805 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.565167e-03 | 2.805 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.565167e-03 | 2.805 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.565167e-03 | 2.805 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.646081e-03 | 2.784 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.598257e-03 | 2.796 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.592382e-03 | 2.798 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.495143e-03 | 2.825 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.520709e-03 | 2.818 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.651715e-03 | 2.782 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.656360e-03 | 2.781 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.729071e-03 | 2.762 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.729071e-03 | 2.762 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.794791e-03 | 2.746 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.904172e-03 | 2.720 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.915405e-03 | 2.718 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.983012e-03 | 2.703 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.983012e-03 | 2.703 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.995544e-03 | 2.700 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.013589e-03 | 2.696 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.094710e-03 | 2.679 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.168355e-03 | 2.664 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.259128e-03 | 2.646 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.437340e-03 | 2.613 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.468610e-03 | 2.608 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.594447e-03 | 2.586 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.437340e-03 | 2.613 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.475528e-03 | 2.606 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.437340e-03 | 2.613 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.281997e-03 | 2.642 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.332651e-03 | 2.632 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.660319e-03 | 2.575 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.660319e-03 | 2.575 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.683640e-03 | 2.571 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.709565e-03 | 2.567 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.747393e-03 | 2.561 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.840374e-03 | 2.547 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.845365e-03 | 2.546 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.918634e-03 | 2.535 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.954312e-03 | 2.530 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.954312e-03 | 2.530 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.991411e-03 | 2.524 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.999927e-03 | 2.523 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.120981e-03 | 2.506 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.162721e-03 | 2.500 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.179275e-03 | 2.498 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.369092e-03 | 2.472 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.505399e-03 | 2.455 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.505399e-03 | 2.455 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.594033e-03 | 2.444 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.626465e-03 | 2.441 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.973897e-03 | 2.401 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.973897e-03 | 2.401 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.014413e-03 | 2.396 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.046415e-03 | 2.393 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.249101e-03 | 2.372 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.249101e-03 | 2.372 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.311652e-03 | 2.365 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.311652e-03 | 2.365 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.045635e-03 | 2.297 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.004674e-03 | 2.301 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.033057e-03 | 2.298 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.816820e-03 | 2.317 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.788532e-03 | 2.320 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.718806e-03 | 2.326 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.139140e-03 | 2.289 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.459476e-03 | 2.351 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.816820e-03 | 2.317 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.045635e-03 | 2.297 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.662252e-03 | 2.331 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.219707e-03 | 2.282 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.406637e-03 | 2.267 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.441921e-03 | 2.264 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.649000e-03 | 2.248 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.664273e-03 | 2.247 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.664273e-03 | 2.247 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.664273e-03 | 2.247 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.664273e-03 | 2.247 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.664273e-03 | 2.247 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.710827e-03 | 2.243 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.710827e-03 | 2.243 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.742470e-03 | 2.241 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.798385e-03 | 2.237 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.954693e-03 | 2.225 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.969071e-03 | 2.224 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.969071e-03 | 2.224 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.972988e-03 | 2.224 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.320940e-03 | 2.199 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.320940e-03 | 2.199 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.320940e-03 | 2.199 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.483780e-03 | 2.188 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.485321e-03 | 2.188 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.485321e-03 | 2.188 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.494332e-03 | 2.187 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.541278e-03 | 2.184 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.611935e-03 | 2.180 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.817972e-03 | 2.166 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.986491e-03 | 2.156 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.131899e-03 | 2.147 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.131899e-03 | 2.147 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.131899e-03 | 2.147 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.026000e-03 | 2.096 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.077580e-03 | 2.093 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.008532e-03 | 2.096 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.956762e-03 | 2.048 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.360905e-03 | 2.133 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.316407e-03 | 2.080 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.763918e-03 | 2.110 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.786778e-03 | 2.056 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.077580e-03 | 2.093 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.196598e-03 | 2.143 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.008532e-03 | 2.096 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.605625e-03 | 2.119 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.605625e-03 | 2.119 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.476099e-03 | 2.126 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.584478e-03 | 2.120 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.491925e-03 | 2.125 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.491925e-03 | 2.125 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.690838e-03 | 2.114 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.946723e-03 | 2.048 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.588534e-03 | 2.120 | 1 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.307582e-03 | 2.136 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.026000e-03 | 2.096 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.956762e-03 | 2.048 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.861161e-03 | 2.105 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.151494e-03 | 2.089 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.410321e-03 | 2.075 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.410321e-03 | 2.075 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.366830e-03 | 2.028 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.596353e-03 | 2.018 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.596353e-03 | 2.018 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.596353e-03 | 2.018 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.596353e-03 | 2.018 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.596353e-03 | 2.018 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.596353e-03 | 2.018 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.596353e-03 | 2.018 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.616479e-03 | 2.017 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.616479e-03 | 2.017 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.616479e-03 | 2.017 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.786852e-03 | 2.009 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.829653e-03 | 2.007 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.940553e-03 | 2.003 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.940553e-03 | 2.003 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.940553e-03 | 2.003 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.003087e-02 | 1.999 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.033316e-02 | 1.986 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.046162e-02 | 1.980 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.051827e-02 | 1.978 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.051827e-02 | 1.978 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.064948e-02 | 1.973 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.064948e-02 | 1.973 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.105475e-02 | 1.956 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.106989e-02 | 1.956 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.124106e-02 | 1.949 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.138466e-02 | 1.944 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.145292e-02 | 1.941 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.145292e-02 | 1.941 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.192885e-02 | 1.923 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.209107e-02 | 1.918 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.209107e-02 | 1.918 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.209859e-02 | 1.917 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.221639e-02 | 1.913 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.225530e-02 | 1.912 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.225530e-02 | 1.912 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.274597e-02 | 1.895 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.297410e-02 | 1.887 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.300029e-02 | 1.886 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.332506e-02 | 1.875 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.353557e-02 | 1.869 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.365364e-02 | 1.865 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.365411e-02 | 1.865 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.535338e-02 | 1.814 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.535338e-02 | 1.814 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.535338e-02 | 1.814 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.535338e-02 | 1.814 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.535338e-02 | 1.814 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.535338e-02 | 1.814 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.811620e-02 | 1.742 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.811620e-02 | 1.742 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.811620e-02 | 1.742 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.500984e-02 | 1.824 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.500984e-02 | 1.824 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.838435e-02 | 1.736 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.457545e-02 | 1.836 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.850865e-02 | 1.733 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.850865e-02 | 1.733 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.638318e-02 | 1.786 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.537208e-02 | 1.813 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.800882e-02 | 1.745 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.800882e-02 | 1.745 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.635056e-02 | 1.786 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.784038e-02 | 1.749 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.811620e-02 | 1.742 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.588184e-02 | 1.799 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.500984e-02 | 1.824 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.588184e-02 | 1.799 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.431779e-02 | 1.844 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.770973e-02 | 1.752 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.415650e-02 | 1.849 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.479301e-02 | 1.830 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.507143e-02 | 1.822 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.413418e-02 | 1.850 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.811620e-02 | 1.742 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.811620e-02 | 1.742 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.746083e-02 | 1.758 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.811620e-02 | 1.742 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.625866e-02 | 1.789 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.415650e-02 | 1.849 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.687193e-02 | 1.773 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.457545e-02 | 1.836 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.856798e-02 | 1.731 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.856798e-02 | 1.731 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.879153e-02 | 1.726 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.910912e-02 | 1.719 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.910912e-02 | 1.719 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.925938e-02 | 1.715 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.011508e-02 | 1.696 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.039020e-02 | 1.691 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.051485e-02 | 1.688 | 1 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.053770e-02 | 1.687 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.053770e-02 | 1.687 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.057622e-02 | 1.687 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.057622e-02 | 1.687 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.093893e-02 | 1.679 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.093893e-02 | 1.679 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.144668e-02 | 1.669 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.144668e-02 | 1.669 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.204314e-02 | 1.657 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.216658e-02 | 1.654 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.224377e-02 | 1.653 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.224377e-02 | 1.653 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.277498e-02 | 1.643 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.342815e-02 | 1.630 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.353433e-02 | 1.628 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.414236e-02 | 1.617 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.414236e-02 | 1.617 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.418540e-02 | 1.616 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.436098e-02 | 1.613 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.439430e-02 | 1.613 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.457189e-02 | 1.610 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.466825e-02 | 1.608 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.557322e-02 | 1.592 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.618739e-02 | 1.582 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.640003e-02 | 1.578 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.641381e-02 | 1.578 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.708007e-02 | 1.567 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.754095e-02 | 1.560 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.774627e-02 | 1.557 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.814601e-02 | 1.551 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.814601e-02 | 1.551 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.823113e-02 | 1.549 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.858482e-02 | 1.544 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.858482e-02 | 1.544 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.858482e-02 | 1.544 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.874152e-02 | 1.541 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.885770e-02 | 1.540 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.889197e-02 | 1.539 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.948207e-02 | 1.530 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.948207e-02 | 1.530 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.948207e-02 | 1.530 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.948207e-02 | 1.530 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.951419e-02 | 1.530 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.069971e-02 | 1.513 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.069971e-02 | 1.513 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.097432e-02 | 1.509 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.137241e-02 | 1.503 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.151931e-02 | 1.501 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.151931e-02 | 1.501 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.213446e-02 | 1.493 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.250026e-02 | 1.488 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.250591e-02 | 1.488 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.250591e-02 | 1.488 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.281048e-02 | 1.484 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.321335e-02 | 1.479 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.387061e-02 | 1.470 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.425778e-02 | 1.465 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.425778e-02 | 1.465 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.989505e-02 | 1.399 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.351941e-02 | 1.361 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.351941e-02 | 1.361 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.351941e-02 | 1.361 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.351941e-02 | 1.361 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.113160e-02 | 1.386 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.300690e-02 | 1.366 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.732427e-02 | 1.428 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.732427e-02 | 1.428 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.101064e-02 | 1.387 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.477329e-02 | 1.459 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.600433e-02 | 1.337 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.320776e-02 | 1.364 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.320776e-02 | 1.364 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.320776e-02 | 1.364 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.435490e-02 | 1.353 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.874664e-02 | 1.312 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.089238e-02 | 1.388 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.071069e-02 | 1.390 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.148542e-02 | 1.288 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.625170e-02 | 1.441 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.986736e-02 | 1.399 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.986736e-02 | 1.399 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.883513e-02 | 1.411 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.473449e-02 | 1.459 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.435490e-02 | 1.353 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.331571e-02 | 1.363 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.331571e-02 | 1.363 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.331571e-02 | 1.363 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.600433e-02 | 1.337 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.300690e-02 | 1.366 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.572527e-02 | 1.447 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.985584e-02 | 1.400 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.331571e-02 | 1.363 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.477329e-02 | 1.459 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.883513e-02 | 1.411 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.732427e-02 | 1.428 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.944143e-02 | 1.404 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.697815e-02 | 1.432 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.101064e-02 | 1.387 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.758742e-02 | 1.425 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.758742e-02 | 1.425 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.113160e-02 | 1.386 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.750217e-02 | 1.426 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.883513e-02 | 1.411 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.395513e-02 | 1.357 | 1 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.113160e-02 | 1.386 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.509302e-02 | 1.455 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.351941e-02 | 1.361 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.089238e-02 | 1.388 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.017791e-02 | 1.299 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.300690e-02 | 1.366 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.758742e-02 | 1.425 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.732427e-02 | 1.428 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.019055e-02 | 1.299 | 1 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.435490e-02 | 1.353 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.148542e-02 | 1.288 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.113160e-02 | 1.386 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.300690e-02 | 1.366 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.300690e-02 | 1.366 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.189357e-02 | 1.285 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.252103e-02 | 1.280 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.271368e-02 | 1.278 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.291545e-02 | 1.276 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.291545e-02 | 1.276 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.299141e-02 | 1.276 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.313021e-02 | 1.275 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.313021e-02 | 1.275 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.313021e-02 | 1.275 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.342042e-02 | 1.272 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.343695e-02 | 1.272 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.343695e-02 | 1.272 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.343695e-02 | 1.272 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.343695e-02 | 1.272 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.440404e-02 | 1.264 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.440404e-02 | 1.264 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.440404e-02 | 1.264 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.440404e-02 | 1.264 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.539389e-02 | 1.257 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.590344e-02 | 1.253 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.681923e-02 | 1.246 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.681923e-02 | 1.246 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.714430e-02 | 1.243 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.721448e-02 | 1.242 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.721448e-02 | 1.242 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.721448e-02 | 1.242 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.826303e-02 | 1.235 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.838125e-02 | 1.234 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.961518e-02 | 1.225 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.971461e-02 | 1.224 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.119934e-02 | 1.213 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.230183e-02 | 1.205 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.230183e-02 | 1.205 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.268544e-02 | 1.203 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.268544e-02 | 1.203 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.387568e-02 | 1.195 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.394632e-02 | 1.194 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.394632e-02 | 1.194 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.394632e-02 | 1.194 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.433893e-02 | 1.192 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.447428e-02 | 1.191 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.447428e-02 | 1.191 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.447428e-02 | 1.191 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.447428e-02 | 1.191 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.447428e-02 | 1.191 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.447428e-02 | 1.191 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.447428e-02 | 1.191 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.461579e-02 | 1.190 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.576748e-02 | 1.182 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.605699e-02 | 1.180 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.605699e-02 | 1.180 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.605699e-02 | 1.180 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.605699e-02 | 1.180 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.643045e-02 | 1.178 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.643045e-02 | 1.178 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.819277e-02 | 1.166 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.835002e-02 | 1.165 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.835002e-02 | 1.165 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.870974e-02 | 1.163 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.982360e-02 | 1.156 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.998396e-02 | 1.155 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.998396e-02 | 1.155 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.058895e-02 | 1.151 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.103261e-02 | 1.149 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.103261e-02 | 1.149 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.235800e-02 | 1.141 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.300823e-02 | 1.137 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.319201e-02 | 1.136 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.502425e-02 | 1.125 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.598011e-02 | 1.119 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.633305e-02 | 1.117 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.660518e-02 | 1.116 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.660518e-02 | 1.116 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.766118e-02 | 1.110 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.827731e-02 | 1.106 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.827731e-02 | 1.106 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.006827e-02 | 1.097 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 8.006827e-02 | 1.097 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 8.006827e-02 | 1.097 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.116735e-02 | 1.091 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.304016e-02 | 1.081 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.408883e-02 | 1.075 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.417043e-02 | 1.075 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.417043e-02 | 1.075 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.417043e-02 | 1.075 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.495759e-02 | 1.071 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.717867e-02 | 1.060 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.717867e-02 | 1.060 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.900269e-02 | 1.051 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.979169e-02 | 1.047 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.979169e-02 | 1.047 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.979826e-02 | 1.047 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.156550e-02 | 1.038 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.156550e-02 | 1.038 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.156550e-02 | 1.038 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.267308e-02 | 1.033 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.267308e-02 | 1.033 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.267308e-02 | 1.033 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.267308e-02 | 1.033 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.267308e-02 | 1.033 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.700887e-01 | 0.769 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.700887e-01 | 0.769 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.700887e-01 | 0.769 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.086556e-01 | 0.964 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.394433e-01 | 0.856 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.394433e-01 | 0.856 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.032803e-01 | 0.986 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.032803e-01 | 0.986 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.032803e-01 | 0.986 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.032803e-01 | 0.986 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.032803e-01 | 0.986 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.718137e-01 | 0.765 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.718137e-01 | 0.765 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.718137e-01 | 0.765 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.718137e-01 | 0.765 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.718137e-01 | 0.765 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.230039e-01 | 0.910 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.230039e-01 | 0.910 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.230039e-01 | 0.910 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.039857e-01 | 0.983 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.191307e-01 | 0.924 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.351632e-01 | 0.869 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.889340e-01 | 0.724 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.889340e-01 | 0.724 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.889340e-01 | 0.724 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.109011e-01 | 0.955 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.109011e-01 | 0.955 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.520143e-01 | 0.818 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.520143e-01 | 0.818 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.238151e-01 | 0.907 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.017139e-01 | 0.993 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.017139e-01 | 0.993 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.696110e-01 | 0.771 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.696110e-01 | 0.771 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.515850e-01 | 0.819 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.878776e-01 | 0.726 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.663646e-01 | 0.779 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.424664e-01 | 0.846 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.537192e-01 | 0.813 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.537192e-01 | 0.813 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.537192e-01 | 0.813 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.365412e-01 | 0.865 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.365412e-01 | 0.865 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.266153e-01 | 0.898 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.670518e-01 | 0.777 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.825755e-01 | 0.739 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.880684e-01 | 0.726 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.481647e-01 | 0.829 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.236844e-01 | 0.908 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.465824e-01 | 0.834 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.498220e-01 | 0.824 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.039857e-01 | 0.983 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.659965e-01 | 0.780 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.198511e-01 | 0.921 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.268608e-01 | 0.897 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.394433e-01 | 0.856 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.032803e-01 | 0.986 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.230039e-01 | 0.910 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.238151e-01 | 0.907 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.132826e-01 | 0.946 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.017463e-01 | 0.992 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.198105e-01 | 0.922 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.039857e-01 | 0.983 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.039857e-01 | 0.983 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.889340e-01 | 0.724 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.124256e-01 | 0.949 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.354714e-01 | 0.868 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.351632e-01 | 0.869 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.214085e-01 | 0.916 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.163680e-01 | 0.934 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.816855e-01 | 0.741 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.052142e-01 | 0.978 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.394433e-01 | 0.856 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.032803e-01 | 0.986 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.718137e-01 | 0.765 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.718137e-01 | 0.765 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.659965e-01 | 0.780 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.017275e-01 | 0.993 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.605416e-01 | 0.794 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.773957e-01 | 0.751 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.465824e-01 | 0.834 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.191307e-01 | 0.924 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.132826e-01 | 0.946 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.889340e-01 | 0.724 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.816855e-01 | 0.741 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.032803e-01 | 0.986 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.816855e-01 | 0.741 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.589842e-01 | 0.799 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.569735e-01 | 0.804 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.852024e-01 | 0.732 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.816855e-01 | 0.741 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.878776e-01 | 0.726 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.086209e-01 | 0.964 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.268608e-01 | 0.897 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.681110e-01 | 0.774 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.109011e-01 | 0.955 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.124256e-01 | 0.949 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.467534e-01 | 0.833 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.467534e-01 | 0.833 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.467534e-01 | 0.833 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.700887e-01 | 0.769 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.700887e-01 | 0.769 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.394433e-01 | 0.856 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.032803e-01 | 0.986 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.032803e-01 | 0.986 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.032803e-01 | 0.986 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.659965e-01 | 0.780 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.112446e-01 | 0.954 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.212148e-01 | 0.916 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.212148e-01 | 0.916 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.661883e-01 | 0.779 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.605416e-01 | 0.794 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.306172e-01 | 0.884 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.365412e-01 | 0.865 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.130146e-01 | 0.947 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.605416e-01 | 0.794 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.069641e-01 | 0.971 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.087341e-01 | 0.964 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.569735e-01 | 0.804 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.351632e-01 | 0.869 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.439647e-01 | 0.842 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.017139e-01 | 0.993 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.124256e-01 | 0.949 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.424664e-01 | 0.846 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.874380e-01 | 0.727 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.008443e-01 | 0.996 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.642173e-02 | 1.016 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 1.718137e-01 | 0.765 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.718137e-01 | 0.765 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 1.718137e-01 | 0.765 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.017275e-01 | 0.993 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.605416e-01 | 0.794 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.881446e-01 | 0.726 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.677019e-01 | 0.775 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.670972e-01 | 0.777 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.265138e-01 | 0.898 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.019806e-01 | 0.991 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.008443e-01 | 0.996 | 1 | 1 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.032803e-01 | 0.986 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.718137e-01 | 0.765 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.867942e-02 | 1.006 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.696110e-01 | 0.771 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.304100e-01 | 0.885 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.238151e-01 | 0.907 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.816855e-01 | 0.741 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.238151e-01 | 0.907 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.776674e-01 | 0.750 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.696110e-01 | 0.771 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.474853e-01 | 0.831 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.424664e-01 | 0.846 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.132826e-01 | 0.946 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.233656e-01 | 0.909 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.760142e-01 | 0.754 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.191307e-01 | 0.924 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.653684e-01 | 0.782 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.020136e-01 | 0.991 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.718137e-01 | 0.765 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.351632e-01 | 0.869 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.439647e-01 | 0.842 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.191307e-01 | 0.924 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.236844e-01 | 0.908 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.897817e-01 | 0.722 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.966083e-01 | 0.706 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.966083e-01 | 0.706 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.975033e-01 | 0.704 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.975033e-01 | 0.704 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.975033e-01 | 0.704 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.975033e-01 | 0.704 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.990564e-01 | 0.701 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.999777e-01 | 0.699 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.010581e-01 | 0.697 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.025059e-01 | 0.694 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.025059e-01 | 0.694 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.052418e-01 | 0.688 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.052418e-01 | 0.688 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.052418e-01 | 0.688 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.052418e-01 | 0.688 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.052516e-01 | 0.688 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.067366e-01 | 0.685 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.126160e-01 | 0.672 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.126160e-01 | 0.672 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.126160e-01 | 0.672 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.126160e-01 | 0.672 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.126160e-01 | 0.672 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.144647e-01 | 0.669 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.155467e-01 | 0.666 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.155467e-01 | 0.666 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.155467e-01 | 0.666 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.155467e-01 | 0.666 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.160610e-01 | 0.665 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.182557e-01 | 0.661 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.222709e-01 | 0.653 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.232493e-01 | 0.651 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.261101e-01 | 0.646 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.261101e-01 | 0.646 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.261101e-01 | 0.646 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.261101e-01 | 0.646 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.288817e-01 | 0.640 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.288817e-01 | 0.640 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.290583e-01 | 0.640 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.304460e-01 | 0.637 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.368872e-01 | 0.625 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.392832e-01 | 0.621 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.392832e-01 | 0.621 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.392832e-01 | 0.621 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.392832e-01 | 0.621 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.392832e-01 | 0.621 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.392832e-01 | 0.621 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.392832e-01 | 0.621 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.392832e-01 | 0.621 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.392832e-01 | 0.621 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.398262e-01 | 0.620 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.439618e-01 | 0.613 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.439618e-01 | 0.613 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.439618e-01 | 0.613 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.439618e-01 | 0.613 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.439618e-01 | 0.613 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.439618e-01 | 0.613 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.439618e-01 | 0.613 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.440706e-01 | 0.612 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.454561e-01 | 0.610 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.457850e-01 | 0.609 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.462383e-01 | 0.609 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.474767e-01 | 0.606 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.474767e-01 | 0.606 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.510150e-01 | 0.600 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.510150e-01 | 0.600 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.510150e-01 | 0.600 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.512891e-01 | 0.600 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.536390e-01 | 0.596 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.563414e-01 | 0.591 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.611378e-01 | 0.583 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.611378e-01 | 0.583 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.616000e-01 | 0.582 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.616000e-01 | 0.582 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.644050e-01 | 0.578 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.644050e-01 | 0.578 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.648169e-01 | 0.577 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.660905e-01 | 0.575 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.660905e-01 | 0.575 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.660905e-01 | 0.575 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.735642e-01 | 0.563 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.735642e-01 | 0.563 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.735642e-01 | 0.563 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.735642e-01 | 0.563 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.735642e-01 | 0.563 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.735642e-01 | 0.563 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.735642e-01 | 0.563 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.765884e-01 | 0.558 | 1 | 1 |
| Glycogen metabolism | R-HSA-8982491 | 2.767318e-01 | 0.558 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.824192e-01 | 0.549 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.846945e-01 | 0.546 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.846945e-01 | 0.546 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.850683e-01 | 0.545 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.865457e-01 | 0.543 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.865457e-01 | 0.543 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.866153e-01 | 0.543 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.866153e-01 | 0.543 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.866153e-01 | 0.543 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.866153e-01 | 0.543 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.893027e-01 | 0.539 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.901916e-01 | 0.537 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.917090e-01 | 0.535 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.917791e-01 | 0.535 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.917791e-01 | 0.535 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.919285e-01 | 0.535 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.967457e-01 | 0.528 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.002367e-01 | 0.523 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.002367e-01 | 0.523 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.002367e-01 | 0.523 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.002367e-01 | 0.523 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.002367e-01 | 0.523 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.072135e-01 | 0.513 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.072135e-01 | 0.513 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.077728e-01 | 0.512 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.077728e-01 | 0.512 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.077728e-01 | 0.512 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.077728e-01 | 0.512 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.077728e-01 | 0.512 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.077728e-01 | 0.512 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.077728e-01 | 0.512 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.085124e-01 | 0.511 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.085124e-01 | 0.511 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.085446e-01 | 0.511 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.112632e-01 | 0.507 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.112632e-01 | 0.507 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.112632e-01 | 0.507 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.112632e-01 | 0.507 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.112632e-01 | 0.507 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.112632e-01 | 0.507 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.112632e-01 | 0.507 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.112632e-01 | 0.507 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.137462e-01 | 0.503 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.182233e-01 | 0.497 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.182233e-01 | 0.497 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.182233e-01 | 0.497 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.210702e-01 | 0.493 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.246338e-01 | 0.489 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.280239e-01 | 0.484 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.324524e-01 | 0.478 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.363339e-01 | 0.473 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.370459e-01 | 0.472 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.370459e-01 | 0.472 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.370459e-01 | 0.472 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.370459e-01 | 0.472 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.370459e-01 | 0.472 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.408664e-01 | 0.467 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.416504e-01 | 0.466 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.416504e-01 | 0.466 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.416504e-01 | 0.466 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.416504e-01 | 0.466 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.416504e-01 | 0.466 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.416504e-01 | 0.466 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.416504e-01 | 0.466 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.489104e-01 | 0.457 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.545250e-01 | 0.450 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.545250e-01 | 0.450 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.571789e-01 | 0.447 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.622322e-01 | 0.441 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.622322e-01 | 0.441 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.622322e-01 | 0.441 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.622322e-01 | 0.441 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.622322e-01 | 0.441 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.658068e-01 | 0.437 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.715878e-01 | 0.430 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.725772e-01 | 0.429 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.725772e-01 | 0.429 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.725772e-01 | 0.429 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 3.725772e-01 | 0.429 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.725772e-01 | 0.429 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 3.725772e-01 | 0.429 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.725772e-01 | 0.429 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.725772e-01 | 0.429 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.727544e-01 | 0.429 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.727544e-01 | 0.429 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.727544e-01 | 0.429 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.749851e-01 | 0.426 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.749851e-01 | 0.426 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.749851e-01 | 0.426 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.760496e-01 | 0.425 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.811712e-01 | 0.419 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.872635e-01 | 0.412 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.872635e-01 | 0.412 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.899221e-01 | 0.409 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.906624e-01 | 0.408 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.906624e-01 | 0.408 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.906624e-01 | 0.408 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.966851e-01 | 0.402 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.049483e-01 | 0.393 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.057721e-01 | 0.392 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.074285e-01 | 0.390 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.076052e-01 | 0.390 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.076052e-01 | 0.390 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.076052e-01 | 0.390 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.076052e-01 | 0.390 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.076052e-01 | 0.390 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.091680e-01 | 0.388 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.114130e-01 | 0.386 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.114130e-01 | 0.386 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.114130e-01 | 0.386 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.114130e-01 | 0.386 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.120506e-01 | 0.385 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.136624e-01 | 0.383 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.138514e-01 | 0.383 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.226301e-01 | 0.374 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.272771e-01 | 0.369 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.284360e-01 | 0.368 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.284360e-01 | 0.368 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.284360e-01 | 0.368 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.284360e-01 | 0.368 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.284360e-01 | 0.368 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.284360e-01 | 0.368 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.284360e-01 | 0.368 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.284360e-01 | 0.368 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.284360e-01 | 0.368 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.304029e-01 | 0.366 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.331046e-01 | 0.363 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.331046e-01 | 0.363 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.365140e-01 | 0.360 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.365140e-01 | 0.360 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.393738e-01 | 0.357 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.393738e-01 | 0.357 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.393738e-01 | 0.357 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.393738e-01 | 0.357 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.393738e-01 | 0.357 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.393738e-01 | 0.357 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.426998e-01 | 0.354 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.429479e-01 | 0.354 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.452741e-01 | 0.351 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.452741e-01 | 0.351 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.452741e-01 | 0.351 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.524051e-01 | 0.344 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.605835e-01 | 0.337 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.631267e-01 | 0.334 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.631267e-01 | 0.334 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.701841e-01 | 0.328 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.701841e-01 | 0.328 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.701841e-01 | 0.328 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.719998e-01 | 0.326 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.719998e-01 | 0.326 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.744110e-01 | 0.324 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.775690e-01 | 0.321 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.793249e-01 | 0.319 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.793249e-01 | 0.319 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.793249e-01 | 0.319 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.793249e-01 | 0.319 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.793249e-01 | 0.319 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.793249e-01 | 0.319 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.793249e-01 | 0.319 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.793249e-01 | 0.319 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.793249e-01 | 0.319 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.793249e-01 | 0.319 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.793249e-01 | 0.319 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.793249e-01 | 0.319 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.793249e-01 | 0.319 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.793249e-01 | 0.319 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.793803e-01 | 0.319 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.808044e-01 | 0.318 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.808044e-01 | 0.318 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.841980e-01 | 0.315 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.841980e-01 | 0.315 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.924212e-01 | 0.308 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.924212e-01 | 0.308 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.924212e-01 | 0.308 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.964993e-01 | 0.304 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.999549e-01 | 0.301 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.999549e-01 | 0.301 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.028762e-01 | 0.299 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.065389e-01 | 0.295 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.066950e-01 | 0.295 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.066950e-01 | 0.295 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.073046e-01 | 0.295 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.119667e-01 | 0.291 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.119667e-01 | 0.291 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.141171e-01 | 0.289 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.256856e-01 | 0.279 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.256856e-01 | 0.279 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.256856e-01 | 0.279 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.256856e-01 | 0.279 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.256856e-01 | 0.279 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.256856e-01 | 0.279 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.256856e-01 | 0.279 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.256856e-01 | 0.279 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.256856e-01 | 0.279 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.256856e-01 | 0.279 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.256856e-01 | 0.279 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.256856e-01 | 0.279 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.256856e-01 | 0.279 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.256856e-01 | 0.279 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.256856e-01 | 0.279 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.256856e-01 | 0.279 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.286272e-01 | 0.277 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.286272e-01 | 0.277 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.286272e-01 | 0.277 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.298586e-01 | 0.276 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 5.298586e-01 | 0.276 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.298586e-01 | 0.276 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.298586e-01 | 0.276 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.311599e-01 | 0.275 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.311599e-01 | 0.275 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.325185e-01 | 0.274 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.496872e-01 | 0.260 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.499727e-01 | 0.260 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.518223e-01 | 0.258 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.561605e-01 | 0.255 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.561605e-01 | 0.255 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.561605e-01 | 0.255 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.561605e-01 | 0.255 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.561605e-01 | 0.255 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.563509e-01 | 0.255 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.625792e-01 | 0.250 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.631276e-01 | 0.249 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.636169e-01 | 0.249 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.679209e-01 | 0.246 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.679209e-01 | 0.246 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.679209e-01 | 0.246 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.679209e-01 | 0.246 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.679209e-01 | 0.246 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 5.679209e-01 | 0.246 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.679209e-01 | 0.246 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.683804e-01 | 0.245 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.683804e-01 | 0.245 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.731652e-01 | 0.242 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.767767e-01 | 0.239 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.825304e-01 | 0.235 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.825304e-01 | 0.235 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.825304e-01 | 0.235 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.825304e-01 | 0.235 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.825304e-01 | 0.235 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.832777e-01 | 0.234 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.880075e-01 | 0.231 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.919067e-01 | 0.228 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.938630e-01 | 0.226 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.938630e-01 | 0.226 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.981263e-01 | 0.223 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.038986e-01 | 0.219 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.038986e-01 | 0.219 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.055096e-01 | 0.218 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.063976e-01 | 0.217 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.063976e-01 | 0.217 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.063976e-01 | 0.217 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.063976e-01 | 0.217 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.063976e-01 | 0.217 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.063976e-01 | 0.217 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.063976e-01 | 0.217 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.063976e-01 | 0.217 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.063976e-01 | 0.217 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.063976e-01 | 0.217 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.063976e-01 | 0.217 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.063976e-01 | 0.217 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.063976e-01 | 0.217 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.063976e-01 | 0.217 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.063976e-01 | 0.217 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.077258e-01 | 0.216 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.077258e-01 | 0.216 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.077258e-01 | 0.216 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.077258e-01 | 0.216 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.077258e-01 | 0.216 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.077258e-01 | 0.216 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.209760e-01 | 0.207 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.209760e-01 | 0.207 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.209760e-01 | 0.207 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.209760e-01 | 0.207 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.214007e-01 | 0.207 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.214007e-01 | 0.207 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.281054e-01 | 0.202 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.317467e-01 | 0.199 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.317467e-01 | 0.199 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.317467e-01 | 0.199 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.317467e-01 | 0.199 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.332537e-01 | 0.198 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.332537e-01 | 0.198 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.395505e-01 | 0.194 | 0 | 0 |
| Translation | R-HSA-72766 | 6.412212e-01 | 0.193 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.414500e-01 | 0.193 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.414500e-01 | 0.193 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.414500e-01 | 0.193 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.414500e-01 | 0.193 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.414500e-01 | 0.193 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.414500e-01 | 0.193 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.414500e-01 | 0.193 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.414500e-01 | 0.193 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.414500e-01 | 0.193 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.414500e-01 | 0.193 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.414500e-01 | 0.193 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.414500e-01 | 0.193 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.414500e-01 | 0.193 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 6.414500e-01 | 0.193 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.414500e-01 | 0.193 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.519246e-01 | 0.186 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.519246e-01 | 0.186 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.519246e-01 | 0.186 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.519246e-01 | 0.186 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.539967e-01 | 0.184 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.546024e-01 | 0.184 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.546024e-01 | 0.184 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.546024e-01 | 0.184 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.546024e-01 | 0.184 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.546024e-01 | 0.184 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.546024e-01 | 0.184 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.546024e-01 | 0.184 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.557204e-01 | 0.183 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.569056e-01 | 0.182 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.572012e-01 | 0.182 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.572012e-01 | 0.182 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.595354e-01 | 0.181 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.601866e-01 | 0.180 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.614423e-01 | 0.180 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.733828e-01 | 0.172 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.733828e-01 | 0.172 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.733828e-01 | 0.172 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.733828e-01 | 0.172 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.733828e-01 | 0.172 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.733828e-01 | 0.172 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.733828e-01 | 0.172 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.733828e-01 | 0.172 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.733828e-01 | 0.172 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.733828e-01 | 0.172 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.741836e-01 | 0.171 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.753917e-01 | 0.170 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.763099e-01 | 0.170 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.763099e-01 | 0.170 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.763099e-01 | 0.170 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.763099e-01 | 0.170 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.763099e-01 | 0.170 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.763099e-01 | 0.170 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.763099e-01 | 0.170 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.763099e-01 | 0.170 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.763099e-01 | 0.170 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.785365e-01 | 0.168 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.844871e-01 | 0.165 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.847616e-01 | 0.164 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.857215e-01 | 0.164 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.871953e-01 | 0.163 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.958002e-01 | 0.158 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.968925e-01 | 0.157 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.968925e-01 | 0.157 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.968925e-01 | 0.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.968925e-01 | 0.157 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.968925e-01 | 0.157 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.968925e-01 | 0.157 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.004928e-01 | 0.155 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.024733e-01 | 0.153 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.024733e-01 | 0.153 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.024733e-01 | 0.153 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.024733e-01 | 0.153 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.024733e-01 | 0.153 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.024733e-01 | 0.153 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.024733e-01 | 0.153 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.024733e-01 | 0.153 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.024733e-01 | 0.153 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.024733e-01 | 0.153 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.108420e-01 | 0.148 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.163782e-01 | 0.145 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.163782e-01 | 0.145 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.176895e-01 | 0.144 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.197171e-01 | 0.143 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.197171e-01 | 0.143 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.218152e-01 | 0.142 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.232845e-01 | 0.141 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.289744e-01 | 0.137 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.289744e-01 | 0.137 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.289744e-01 | 0.137 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.289744e-01 | 0.137 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.289744e-01 | 0.137 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.289744e-01 | 0.137 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.289744e-01 | 0.137 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.289744e-01 | 0.137 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.289744e-01 | 0.137 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.289744e-01 | 0.137 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.347992e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.347992e-01 | 0.134 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.347992e-01 | 0.134 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.347992e-01 | 0.134 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.347992e-01 | 0.134 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.349630e-01 | 0.134 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.349630e-01 | 0.134 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.349630e-01 | 0.134 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.349630e-01 | 0.134 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.401142e-01 | 0.131 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.401142e-01 | 0.131 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.426878e-01 | 0.129 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.470046e-01 | 0.127 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.510299e-01 | 0.124 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.521905e-01 | 0.124 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.521905e-01 | 0.124 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.521905e-01 | 0.124 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.531164e-01 | 0.123 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.531164e-01 | 0.123 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.531164e-01 | 0.123 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.531164e-01 | 0.123 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.531164e-01 | 0.123 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.531164e-01 | 0.123 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.531164e-01 | 0.123 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.531164e-01 | 0.123 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.531164e-01 | 0.123 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.531164e-01 | 0.123 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.545049e-01 | 0.122 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.582856e-01 | 0.120 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.582856e-01 | 0.120 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.582856e-01 | 0.120 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.751092e-01 | 0.111 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.751092e-01 | 0.111 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.751092e-01 | 0.111 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.751092e-01 | 0.111 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.751092e-01 | 0.111 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.751092e-01 | 0.111 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.751092e-01 | 0.111 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.751092e-01 | 0.111 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.751092e-01 | 0.111 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.767737e-01 | 0.110 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.767737e-01 | 0.110 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.797050e-01 | 0.108 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.840344e-01 | 0.106 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.840344e-01 | 0.106 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.840344e-01 | 0.106 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.840344e-01 | 0.106 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.840344e-01 | 0.106 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.840344e-01 | 0.106 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.840344e-01 | 0.106 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.840344e-01 | 0.106 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.894486e-01 | 0.103 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.898519e-01 | 0.102 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.951441e-01 | 0.100 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.951441e-01 | 0.100 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.951441e-01 | 0.100 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.951441e-01 | 0.100 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.951441e-01 | 0.100 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.951441e-01 | 0.100 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.951441e-01 | 0.100 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.951441e-01 | 0.100 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.985655e-01 | 0.098 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.985655e-01 | 0.098 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.985655e-01 | 0.098 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.987678e-01 | 0.098 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.996305e-01 | 0.097 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.998113e-01 | 0.097 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.107809e-01 | 0.091 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.109847e-01 | 0.091 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.122229e-01 | 0.090 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.122229e-01 | 0.090 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.130038e-01 | 0.090 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.130038e-01 | 0.090 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.130038e-01 | 0.090 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.133952e-01 | 0.090 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.133952e-01 | 0.090 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.133952e-01 | 0.090 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.133952e-01 | 0.090 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.133952e-01 | 0.090 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.133952e-01 | 0.090 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.133952e-01 | 0.090 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.133952e-01 | 0.090 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.133952e-01 | 0.090 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.133952e-01 | 0.090 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.133952e-01 | 0.090 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.190267e-01 | 0.087 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.250468e-01 | 0.084 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.250468e-01 | 0.084 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.250468e-01 | 0.084 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.250468e-01 | 0.084 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.300213e-01 | 0.081 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.300213e-01 | 0.081 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.300213e-01 | 0.081 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.300213e-01 | 0.081 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.300213e-01 | 0.081 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.300213e-01 | 0.081 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.300213e-01 | 0.081 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.300213e-01 | 0.081 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.300213e-01 | 0.081 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.300213e-01 | 0.081 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.300213e-01 | 0.081 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.300213e-01 | 0.081 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.300213e-01 | 0.081 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.351161e-01 | 0.078 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.369045e-01 | 0.077 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.370773e-01 | 0.077 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.375746e-01 | 0.077 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.435890e-01 | 0.074 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.441236e-01 | 0.074 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.451669e-01 | 0.073 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.451669e-01 | 0.073 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.451669e-01 | 0.073 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.451669e-01 | 0.073 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.451669e-01 | 0.073 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.451669e-01 | 0.073 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.451669e-01 | 0.073 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.451669e-01 | 0.073 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.483540e-01 | 0.071 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.498157e-01 | 0.071 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.589156e-01 | 0.066 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.589156e-01 | 0.066 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.589156e-01 | 0.066 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.589156e-01 | 0.066 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.589638e-01 | 0.066 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.589638e-01 | 0.066 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.589638e-01 | 0.066 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.622847e-01 | 0.064 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.654105e-01 | 0.063 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.667642e-01 | 0.062 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.688000e-01 | 0.061 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.688000e-01 | 0.061 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.690364e-01 | 0.061 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.699070e-01 | 0.061 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.706480e-01 | 0.060 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.715321e-01 | 0.060 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.715321e-01 | 0.060 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.715321e-01 | 0.060 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.721933e-01 | 0.059 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.768673e-01 | 0.057 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.780440e-01 | 0.056 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.788043e-01 | 0.056 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.829810e-01 | 0.054 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.829810e-01 | 0.054 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.829810e-01 | 0.054 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.829810e-01 | 0.054 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.829810e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.866831e-01 | 0.052 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.866831e-01 | 0.052 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.875448e-01 | 0.052 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.903711e-01 | 0.050 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.903711e-01 | 0.050 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.903711e-01 | 0.050 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.931010e-01 | 0.049 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.934102e-01 | 0.049 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.934102e-01 | 0.049 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.934102e-01 | 0.049 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.947030e-01 | 0.048 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.947518e-01 | 0.048 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.947518e-01 | 0.048 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.947518e-01 | 0.048 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.981847e-01 | 0.047 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.021570e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.022830e-01 | 0.045 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.029105e-01 | 0.044 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.029105e-01 | 0.044 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.029105e-01 | 0.044 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.029105e-01 | 0.044 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.029105e-01 | 0.044 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.029105e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.060602e-01 | 0.043 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.092904e-01 | 0.041 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.093085e-01 | 0.041 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.093085e-01 | 0.041 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.093085e-01 | 0.041 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.115645e-01 | 0.040 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.115645e-01 | 0.040 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.115645e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.115645e-01 | 0.040 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.125283e-01 | 0.040 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.125283e-01 | 0.040 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.158586e-01 | 0.038 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.169032e-01 | 0.038 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.182480e-01 | 0.037 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.194477e-01 | 0.036 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.194477e-01 | 0.036 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.194477e-01 | 0.036 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.218386e-01 | 0.035 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.219620e-01 | 0.035 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.219620e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.266285e-01 | 0.033 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.266285e-01 | 0.033 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.266285e-01 | 0.033 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.266285e-01 | 0.033 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.291836e-01 | 0.032 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.324569e-01 | 0.030 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.329381e-01 | 0.030 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.329381e-01 | 0.030 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.331696e-01 | 0.030 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.331696e-01 | 0.030 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.331696e-01 | 0.030 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.331696e-01 | 0.030 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.331696e-01 | 0.030 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.331696e-01 | 0.030 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.378617e-01 | 0.028 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.378617e-01 | 0.028 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.391280e-01 | 0.027 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.391280e-01 | 0.027 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.399166e-01 | 0.027 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.432097e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.445554e-01 | 0.025 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.445554e-01 | 0.025 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.445554e-01 | 0.025 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.445554e-01 | 0.025 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.445554e-01 | 0.025 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.448231e-01 | 0.025 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.448231e-01 | 0.025 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.484540e-01 | 0.023 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.494992e-01 | 0.023 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.494992e-01 | 0.023 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.494992e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.498406e-01 | 0.022 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.511365e-01 | 0.022 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.516410e-01 | 0.022 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.518614e-01 | 0.021 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.540024e-01 | 0.020 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.540024e-01 | 0.020 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.540024e-01 | 0.020 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.540024e-01 | 0.020 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.540024e-01 | 0.020 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.540024e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.541329e-01 | 0.020 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.543281e-01 | 0.020 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.543281e-01 | 0.020 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.550575e-01 | 0.020 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.555513e-01 | 0.020 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.555513e-01 | 0.020 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.555513e-01 | 0.020 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.568428e-01 | 0.019 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.570834e-01 | 0.019 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.577399e-01 | 0.019 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.577399e-01 | 0.019 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.581044e-01 | 0.019 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.581044e-01 | 0.019 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.581044e-01 | 0.019 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.606534e-01 | 0.017 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.609067e-01 | 0.017 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.609067e-01 | 0.017 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.618407e-01 | 0.017 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.648164e-01 | 0.016 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.652441e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.652441e-01 | 0.015 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.665705e-01 | 0.015 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.675702e-01 | 0.014 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.690976e-01 | 0.014 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.701169e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.704217e-01 | 0.013 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.714401e-01 | 0.013 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.737396e-01 | 0.012 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.737396e-01 | 0.012 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.739929e-01 | 0.011 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.760823e-01 | 0.011 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.760823e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.774837e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.777409e-01 | 0.010 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.777409e-01 | 0.010 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.777409e-01 | 0.010 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.782161e-01 | 0.010 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.782161e-01 | 0.010 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.782161e-01 | 0.010 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.801596e-01 | 0.009 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.801596e-01 | 0.009 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.801596e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.801596e-01 | 0.009 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.801596e-01 | 0.009 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.819299e-01 | 0.008 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.819299e-01 | 0.008 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.835423e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.836466e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.842341e-01 | 0.007 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.850109e-01 | 0.007 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.855732e-01 | 0.006 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.860785e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.863485e-01 | 0.006 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.863485e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.872858e-01 | 0.006 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.875669e-01 | 0.005 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.875669e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.881569e-01 | 0.005 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.881569e-01 | 0.005 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.896872e-01 | 0.005 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.896872e-01 | 0.005 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.896872e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.896872e-01 | 0.005 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.896872e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.906078e-01 | 0.004 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.907187e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.914462e-01 | 0.004 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.914462e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.914463e-01 | 0.004 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.919679e-01 | 0.004 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.922098e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.922098e-01 | 0.003 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.922098e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.922098e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.923492e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.929053e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.931144e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.933081e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.941157e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.943226e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.949592e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.950412e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.950412e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.955022e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.955555e-01 | 0.002 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.955678e-01 | 0.002 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.959857e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.963797e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.964416e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.965157e-01 | 0.002 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.970735e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.970735e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.978030e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.982565e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.984123e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.986834e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.988011e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.990943e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.990947e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.990947e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.993165e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.993776e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.993776e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.993853e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.995785e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.996698e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.996698e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997059e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.997561e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997897e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998159e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998484e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998844e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999000e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999045e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999208e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999250e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999250e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999344e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999456e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999549e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999621e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999626e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999678e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999766e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999784e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999792e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999793e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999876e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999878e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999879e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999898e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999900e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999903e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999916e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999936e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999951e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999955e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999975e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999984e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999989e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999995e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |